UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No.)
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
☐
|
Preliminary Proxy Statement
|
☐
|
Confidential, for Use of the
Commission Only (as permitted by Rule 14a-6(e)(2))
|
☒
|
Definitive Proxy Statement
|
☐
|
Definitive Additional Materials
|
☐
|
Soliciting Material Pursuant to §240.14a-12
|
AMERISAFE, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the
Registrant)
Payment of Filing Fee (Check all boxes that apply):
☐
|
Fee paid previously with preliminary materials
|
☐
|
Fee computed on table in exhibit required by Item 25(b) per
Exchange Act Rules 14a-6(i)(1) and 0-11
|


FROM OUR
Chairman of the Board
|
|
|
|
April 29, 2022
Dear AMERISAFE Shareholder:
You are cordially invited to attend the annual meeting of
shareholders of AMERISAFE, Inc. The meeting will be held on Friday,
June 10, 2022, beginning at 9:00 a.m. CST at our corporate
headquarters, which are located at 2301 Highway 190 West in
DeRidder, Louisiana 70634.
Information about the meeting, including the nominees for election
as directors and the other proposals to be considered is presented
in the following notice of annual meeting and proxy statement. At
the meeting, management will report on the Company’s operations
during 2021 and comment on our outlook for the remainder of 2022.
The report will be followed by a question and answer period.
We hope that you will attend the annual meeting. It is important
that your shares be represented. Accordingly, please vote using the
internet or telephone procedures described on the proxy card or
sign, date and promptly mail the enclosed proxy card in the
enclosed pre-addressed, postage-paid envelope.
We look forward to seeing you at the meeting on June 10th.
|

|
|
|
Sincerely,
|
|
|
|
|
|

|
|
|
|
Jared A. Morris
Chairman
|
|
|
|
|
|


NOTICE OF ANNUAL MEETING OF SHAREHOLDERS
To be held on June 10, 2022
The 2022 annual meeting of shareholders of AMERISAFE, Inc. (the
“Company”) will be held on June 10, 2022, beginning at 9:00 a.m.
CST at the Company’s corporate headquarters, which are located at
2301 Highway 190 West in DeRidder, Louisiana 70634. The meeting
will be held for the following purposes:
|
1.
|
to elect three directors to serve until the 2025 annual meeting of
shareholders;
|
|
2.
|
to approve the Company’s 2022 Equity and Incentive Compensation
Plan;
|
|
3.
|
to conduct an advisory vote on the Company’s executive
compensation;
|
|
4.
|
to ratify the appointment of Ernst & Young LLP as the
Company’s independent registered public accounting firm for 2022;
and
|
|
5.
|
to transact such other business as may properly come before the
meeting.
|
Information concerning the matters to be voted upon at the meeting
is set forth in the accompanying proxy statement. Also enclosed is
the Company’s annual report for the year ended December 31, 2021.
Holders of record of the Company’s common stock as of the close of
business on April 18, 2022 are entitled to notice of, and to
vote at, the meeting.
If you plan to attend the meeting and will need special assistance
or accommodation, please describe your needs on the enclosed proxy
card.
|
By Order of the Board of Directors,
|
|

|
|
Kathryn H. Shirley
|
|
Executive Vice President,
Chief Administrative Officer
and Secretary
|
IMPORTANT
Whether or not you plan to attend the meeting in person, please
vote using the internet or telephone procedures described on the
proxy card or by signing, dating, and promptly returning the
enclosed proxy card in the pre-addressed, postage-paid
envelope.
|
DeRidder, Louisiana
April 29, 2022
TABLE OF CONTENTS
AMERISAFE, Inc.
2301 Highway 190 West
DeRidder, Louisiana 70634
PROXY STATEMENT
This proxy statement provides information in connection with the
solicitation of proxies by the Board of Directors (the “Board”) of
AMERISAFE, Inc. (the “Company”) for use at the Company’s 2022
annual meeting of shareholders or any postponement or adjournment
thereof (the “Annual Meeting”). This proxy statement also provides
information you will need in order to consider and act upon the
matters specified in the accompanying notice of annual meeting.
This proxy statement and the enclosed proxy card are being mailed
to shareholders on or about May 3, 2022.
Record holders of the Company’s common stock as of the close of
business on April 18, 2022 are entitled to vote at the Annual
Meeting. Each record holder of common stock on that date is
entitled to one vote at the Annual Meeting for each share of common
stock held. As of April 18, 2022, there were 19,320,422 shares of
common stock outstanding.
You cannot vote your shares unless you are present at the Annual
Meeting or you have properly executed your proxy. You can vote by
proxy in one of three convenient ways:
|
•
|
by internet: visit the website shown on your proxy card and follow
the instructions;
|
|
•
|
by telephone: dial the toll-free number shown on your proxy card
and follow the instructions; or
|
|
•
|
in writing: sign, date, and return the enclosed proxy card in the
enclosed pre-addressed, postage paid envelope.
|
You may revoke your proxy at any time prior to the vote at the
Annual Meeting by:
|
•
|
delivering a written notice revoking your proxy to the Company’s
Secretary at the address above;
|
|
•
|
delivering a new proxy bearing a date after the date of the proxy
being revoked; or
|
|
•
|
voting in person at the Annual Meeting.
|
Unless revoked as described above, all properly executed proxies
will be voted at the Annual Meeting in accordance with your
directions on the proxy. If a properly executed proxy gives no
specific instructions, the shares of common stock represented by
your proxy will be voted:
|
•
|
FOR the election of three directors to serve until the 2025 annual
meeting of shareholders;
|
|
•
|
FOR
the approval of the 2022 Equity and Incentive Compensation
Plan;
|
|
•
|
FOR the approval of the compensation of our executive officers, as
disclosed in this proxy statement;
|
|
•
|
FOR the ratification of the appointment of Ernst & Young
LLP as the Company’s independent registered public accounting firm
for 2022; and
|
|
•
|
at the discretion of the proxy holders with regard to any other
matter that is properly presented at the Annual Meeting.
|
If you own shares of common stock held in “street name” and you do
not instruct your broker how to vote your shares using the
instructions your broker provides you, your shares will be voted in
the ratification of the appointment of Ernst & Young as
the Company’s independent registered public accounting firm for
2022, but not for any other proposal. To be sure your shares are
voted in the manner you desire, you should instruct your broker how
to vote your shares.
Holders of a majority of the outstanding shares of the Company’s
common stock must be present, either in person or by proxy, to
constitute a quorum necessary to conduct the Annual Meeting.
- 1 -
Abstentions and broker non-votes are counted for purposes of
determining a quorum and are considered present and entitled to
vote.
The following table sets forth the voting requirements, whether
broker discretionary voting is allowed and the treatment of
abstentions and broker non-votes for each of the matters to be
voted on at the Annual Meeting.
Proposal
|
|
Vote Necessary to
Approve Proposal
|
|
Broker Discretionary
Voting Allowed?
|
|
Treatment of Abstentions
and Broker Non-Votes
|
No. 1 –
|
Election of directors
|
|
Plurality (that is, the largest number) of the votes cast; provided
that any director that does not receive a majority of the votes
cast is required to submit his or her resignation
|
|
No
|
|
Abstentions and broker non-votes are not considered votes cast and
will have no effect
|
|
|
|
|
|
|
|
|
No. 2
|
Approval of 2022 Equity and Incentive Compensation
Plan
|
|
Affirmative vote of a majority of the shares present, in person or
by proxy, at the Annual Meeting and entitled to vote on the
matter
|
|
No
|
|
Abstentions will have the effect of a vote cast against the matter
and broker non-votes are not considered votes cast and will have no
effect
|
|
|
|
|
|
|
|
|
No. 3 –
|
Advisory vote on executive compensation
|
|
Affirmative vote of a majority of the shares present, in person or
by proxy, at the Annual Meeting and entitled to vote on the
matter
|
|
No
|
|
Abstentions will have the effect of a vote cast against the matter
and broker non-votes are not considered votes cast and will have no
effect
|
|
|
|
|
|
|
|
|
No. 4 –
|
Ratification of the appointment of Ernst &Young
|
|
Affirmative vote of a majority of the shares present, in person or
by proxy, at the Annual Meeting and entitled to vote on the
matter
|
|
Yes
|
|
Abstentions will have the effect of a vote cast against the
matter
|
The Company pays the costs of soliciting proxies. We have engaged
Georgeson, Inc. to serve as our proxy solicitor for the Annual
Meeting at a base fee of $10,000 plus reimbursement of reasonable
expenses. Georgeson will conduct our broker search, solicit banks,
brokers, institutional investors and hedge funds to determine
voting instructions, monitor voting and deliver executed proxies to
our voting tabulator. Our employees also may solicit proxies by
telephone or in person. However, they will not receive additional
compensation for soliciting proxies. The Company may request banks,
brokers and other custodians, nominees and fiduciaries to forward
copies of these proxy materials to the beneficial holders and to
request instructions for the execution of proxies. The Company may
reimburse these persons for their related expenses. Proxies are
solicited to provide all record holders of the Company’s common
stock an opportunity to vote on the matters to be presented at the
Annual Meeting, even if they cannot attend the meeting in
person.
- 2 -
PROPOSAL 1
ELECTION OF DIRECTORS
At the Annual Meeting, three directors will be elected to serve
three-year terms expiring at our annual shareholder meeting in
2025. This section of the proxy statement contains information
relating to the director nominees and the directors whose terms of
office continue after the Annual Meeting. The director nominees
were selected by the Nominating and Corporate Governance Committee
and approved by the Board for submission to the shareholders. The
nominees for election are Teri G. Fontenot, Billy B. Greer, and
Jared A. Morris, each of whom currently serve as directors.
The Board recommends a vote “FOR” the election of each of the
nominees.
Nominees to be elected for terms expiring at the Annual Meeting in
2025
TERI G. FONTENOT
|
|

|
Age 68, has served as a director of the Company since January
2016
|
|
|
|
|
|
Ms. Fontenot served as President and Chief Executive Officer
of Woman’s Hospital from 1996 until her retirement in March 2019.
Upon her retirement, Ms. Fontenot was named Chief Executive
Officer Emeritus. From 2011 to 2013, Ms. Fontenot served on
the American Hospital Association Board and was the chair in 2012.
Ms. Fontenot has served as a director for LHC Group, Inc., a
national provider of in-home health care services, since March 2019
and AMN Healthcare, a healthcare staffing provider, since September
2019.
|
|
|
|
|
|
|
Ms. Fontenot brings to the Board substantial experience as a
former chief executive officer and chief financial officer of
healthcare institutions and as chair of an insurance provider for
over ten years. Her experience in the healthcare and insurance
industries provide her with valuable insight into the issues
affecting the Company and our policyholders. She is also an
inactive certified public accountant. This experience enables her
to serve on the Audit Committee as an “audit committee financial
expert.”
|
BILLY B. GREER
|
|

|
Age 57, has served as a director of the Company since March
2022
|
|
|
|
|
|
Mr. Greer is Managing Director for PGIM Private Capital, a division
of Prudential Financial, a position he has held since 2012. From
2004 until 2011 Mr. Greer served as Senior Vice President of PGIM
and Vice President from 1999 until 2004. He is also an inactive
certified public accountant.
Mr. Greer possesses deep expertise in the areas of investment
management, business development and asset administration. In
particular, this experience will enhance the Board’s capabilities
with respect to oversight of our investment portfolio.
|
|

|
3
|
JARED A. MORRIS
|
|

|
Age 47, has served as a director of the Company since 2005
|
|
|
|
|
|
Mr. Morris has served as our lead director from November 2012 until
he was appointed Chairman of the Board in April 2016. Since 2002,
he has been an officer and a principal owner of Marine One
Acceptance Corporation and Dumont Land, LLC, both of which are
specialty finance companies. Since 2002, he has also served as an
officer of Dumont Management Group, LLC, a privately held company
that provides management services to various affiliated finance and
investment companies. His experience enables him to serve on the
Audit Committee as an “audit committee financial expert.” He serves
on the board of directors of First National Bank of DeRidder and
the Audit Committee of Beauregard Health System. Jared A. Morris is
the son of Millard E. Morris.
|
|
|
|
|
|
|
Jared A. Morris is currently our Chairman of the Board and the
former chair of the Nominating and Corporate Governance Committee.
In these capacities, he has taken a lead role in developing and
maintaining the Company’s corporate governance policies and
practices. His experience and training in financial and credit
management, as well as business investment, enhances the Board’s
business sophistication.
|

|
4
|
Current directors whose terms expire at the Annual Meeting in
2023
MICHAEL J. BROWN
|
|

|
Age 58, has served as a director of the Company since November
2014
|
|
|
|
|
|
Mr. Brown serves as Chair of the Compensation Committee. Mr.
Brown Mr. Brown was President of Regional Banking for First Horizon
from July 2020, when First Horizon completed its merger with
IberiaBank Corp., until his retirement on December 31, 2021. From
September 2009 until July 2020, Mr. Brown was the Vice
Chairman and Chief Operating Officer of IberiaBank Corp., managing
IberiaBank’s retail and commercial banking operations. From 2001 to
2009, Mr. Brown served as Senior Executive Vice President of
IberiaBank Corp. Prior to joining IberiaBank in 1999,
Mr. Brown was a managing director with Bank One Capital
Markets.
|
|
|
|
|
|
|
Mr. Brown’s experience in the financial services industry in a
number of the Company’s key markets makes him well qualified to
serve as a director of the Company and enables him to serve on the
Audit Committee as an “audit committee financial expert.”
|
G. JANELLE FROST
|
|

|
Age 51, has served as a Director since April 2016
|
|
|
|
|
|
Ms. Frost has served as the Company’s Chief Executive Officer
since April 2015 and President since September 2013. Prior to
becoming Chief Executive Officer, Ms. Frost served as Chief
Operating Officer from May 2013 to April 2015. She served as
Executive Vice President and Chief Financial Officer from November
2008 to April 2013 and Controller from May 2004 to November 2008.
She has been employed with the Company since 1992. Ms. Frost
currently serves as chair of the board of directors of the New
Orleans Branch of the Federal Reserve Bank of Atlanta.
|
|
|
|
|
|
|
Ms. Frost’s over 25 years of experience with the Company and
her performance in numerous roles with the Company gives her
in-depth knowledge of the Company’s business and insurance
industry. Her tenure with the Company provides valuable insight
about operational and strategic matters impacting the Company.
|
SEAN M. TRAYNOR
|
|

|
Age 53, has served as a director of the Company since March
2020
|
|
|
|
|
|
Mr. Traynor previously served as a director for the Company from
2001 until 2013. He is currently a general partner of Welsh,
Carson, Anderson & Stowe, a private equity investment firm
that he joined in March 1999. Mr. Traynor has served as a director
for Innovage Holding Corp., a healthcare company, since 2015 and
Managed Markets Insights and Technology since 2018.
Mr. Traynor has also served as a director for Universal
American Financial Corporation, a health insurer, and K2M, Inc., a
provider of medical products.
|
|
|
|
|
|
|
Mr. Traynor has strong expertise in the insurance and
healthcare industries through his role and as at Welsh, Carson,
Anderson & Stowe, which invests in companies in both
industries. Mr. Traynor’s experience with companies in these
industries provides valuable insight to the Board regarding
industry trends that affect the Company.
|

|
5
|
Current directors whose terms expire at the Annual Meeting in
2024
PHILIP A. GARCIA
|
|

|
Age 65, has served as a director of the Company since 2010
|
|
|
|
|
|
Mr. Garcia serves as Chair of the Audit Committee. He retired
from the Erie Insurance Group in April 2009, where he served as
executive vice president and chief financial officer for the final
12 years of his 28-year career with that company. Mr. Garcia
was a director of Donegal Group Inc. from December 2009 to May
2011.
Mr. Garcia possesses a strong background in financial,
accounting and investment management with a publicly traded
property and casualty insurance company, as evidenced by his prior
service as chief financial
|
|
|
officer of Erie Insurance Group. He brings substantial experience
in the insurance industry to the Board, including a strategic
understanding of the operations of a property and casualty
insurance company, as well as an understanding of the current
economic and other challenges facing our industry. He is also an
inactive certified public accountant. His experience enables him to
serve on the Audit Committee as an “audit committee financial
expert.”
|
MILLARD E. MORRIS
|
|

|
Age 77, founded the Company in 1985
|
|
|
|
|
|
Mr. Morris was our Chairman, Chief Executive Officer and principal
shareholder until the Company was sold to a private investment
group in 1997. He served on the Company’s Board from 1985 until
2005, when he voluntarily retired from our Board prior to the
Company’s initial public offering. Mr. Morris was re-elected
to the Board in June 2007. Mr. Morris serves as Chair of the
Risk Committee. From 1996 until 2015, he served as the managing
member of Dumont Management Group, LLC, a privately held company
that provides management services to various affiliated finance and
investment companies. Millard E. Morris is the father of Jared A.
Morris.
|
|
|
|
|
|
|
Millard E. Morris’s experience as founder of the Company and his
long-term service as a director give him unique knowledge of the
opportunities and challenges associated with the Company’s
business. His familiarity with the Company and the insurance
industry make him uniquely qualified to serve as a director of the
Company.
|

|
6
|
RANDALL E. ROACH
|
|

|
Age 71, has served as a director of the Company since March
2007
|
|
|
|
|
|
Mr. Roach serves as Chair of the Nominating and Corporate
Governance Committee. Mr. Roach is an attorney and served as
the Mayor of Lake Charles, Louisiana from 2000 until 2017. In 2016
he was also appointed to serve on the legislative task force on
Structural Changes in Budget and Tax Policy. Prior to assuming his
duties as Mayor, Mr. Roach served as a member of the Louisiana
House of Representatives from 1988 thru 1995. He also served as
Chairman of the House National Resources Committee in 1994.
|
|
|
|
|
|
|
As a practicing attorney, Mr. Roach was engaged in the practice of
law focusing on real estate, trusts and estate and business law. He
is a director of The First National Bank of Louisiana and Financial
Corporation of Louisiana. Mr. Roach has also served as an adjunct
instructor in the field of Business Law at McNeese State
University.
Mr. Roach’s experience as an attorney and as an elected
government official brings valuable insight to the Board given that
the Company operates in a highly regulated industry.
Mr. Roach’s background as an attorney, legislator and
government official is particularly helpful in his role as a member
of the Nominating and Corporate Governance Committee.
|

|
7
|
PROPOSAL 2
Approval of the AMERISAFE, Inc.
2022 Equity and Incentive Compensation Plan
Overview
We are asking shareholders to approve the AMERISAFE, Inc. 2022
Equity and Incentive Compensation Plan (the “2022
Plan”). Our Board of Directors is recommending that the
Company’s shareholders vote in favor of the 2022 Plan, which will
succeed the AMERISAFE, Inc. 2012 Equity and Incentive Compensation
Plan (the “2012 Plan”). The 2012 Plan has shares
remaining available for new awards as of the date of this proxy
statement, but if the 2022 Plan is approved by our shareholders, no
further grants will be made under the 2012
Plan. However, outstanding awards under the 2012 Plan
will generally continue in effect in accordance with their
terms.
The 2022 Plan will continue to afford the Compensation Committee
the ability to design compensatory awards that are responsive to
the Company’s needs and includes authorization for a variety of
awards designed to advance the interests and long-term success of
the Company by encouraging stock ownership among 2022 Plan
participants.
Shareholder approval of the 2022 Plan would constitute approval of
500,000 common shares, $0.01 par value per share, of the Company
(“Common Shares”) to be available for awards under the 2022 Plan,
as described below and in the 2022 Plan, with such amount subject
to adjustment, including under the 2022 Plan’s share counting
rules. If the 2022 Plan is approved by our shareholders,
it will be effective as of the day of the Annual
Meeting. If the 2022 Plan is not approved by our
shareholders, no awards will be made under the 2022 Plan, and the
2012 Plan will remain in effect until June 15, 2022.
The actual text of the 2022 Plan is attached to this Proxy
Statement as Appendix A. The following description of
the 2022 Plan is only a summary of its principal terms and
provisions and is qualified by reference to the actual text as set
forth in Appendix A.
Why
We Believe You Should Vote for this Proposal
The 2022 Plan authorizes the Compensation Committee to provide cash
awards and equity-based compensation in the forms described below
for the purpose of providing 2022 Plan participants incentives and
rewards for performance and/or service. Some of the key
features of the 2022 Plan that reflect our commitment to effective
management of equity and incentive compensation are set forth below
in this subsection.
We believe our future success depends in part on our ability to
attract, motivate, and retain high quality employees and directors
and that the ability to provide equity-based and incentive-based
awards under the 2022 Plan is critical to achieving this
success. We would be at a significant competitive
disadvantage if we could not use share-based awards to recruit and
compensate our employees and directors. The use of
Common Shares as part of our compensation program is also important
because equity-based awards are an essential component of our
compensation for key employees, as they help link compensation with
long-term shareholder value creation and reward participants based
on service and/or performance.
As of April 18, 2022, 269,839 Common Shares remained available for
issuance under the 2012 Plan, disregarding shares potentially
issuable for outstanding performance-based awards, as described
below. However, as noted above, the 2012 plan will expire by it
terms on June 15, 2022. Therefore, if the 2022 Plan is not
approved, it may be necessary to increase significantly the cash
component of our employee and director compensation, which approach
may not necessarily align employee and director compensation
interests with the investment interests of our
shareholders. Replacing equity awards with cash also
would increase cash compensation expense and use cash that could be
better utilized.
- 8 -
The following includes aggregated information regarding our view of
the overhang and dilution associated with the 2012 Plan, and the
potential dilution associated with the 2022 Plan. This
information is as of
April 18,
2022. As
of that date, there were approximately
19,320,422
Common Shares outstanding. As of that date,
approximately
160,093
shares (approximately
0.8%
of our outstanding Common Shares) were subject to outstanding
awards under the 2012 Plan (consisting of
12,821
time-based restricted shares and the estimated number of shares to
be issued to satisfy performance-based awards
147,272). For
purposes of outstanding performance-based awards (which are
denominated in cash until share settlement), we have calculated an
estimated number of shares to be issued under such awards by
dividing the estimated dollar value of such awards as of September
30,
2021
by the closing price of a Common Share on April 18, 2022. Although
the 2012 Plan does not count shares as used until they are issued
or delivered pursuant to an award, for purposes of this proposal we
view the outstanding awards described above as reducing the
available shares under the 2012 Plan. On that basis,
122,567
shares (approximately
0.6%
of our outstanding Common Shares) were available for future awards
under the 2012 Plan as of
April 18¸2022. As
a result, we view the 2012 Plan as representing an overhang
percentage (in other words, potential dilution of the holders of
Common Shares) of approximately
1.5%
as of
April 18,
2022 (based on the
282,660
total shares subject to outstanding awards and available for future
awards as of such date).
The proposed additional 500,000 Common Shares available for awards
under the 2022 Plan represent approximately 2.6% of our outstanding
Common Shares as of April 18, 2022, a percentage that reflects the
simple dilution of the holders of Common Shares that could occur if
the 2022 Plan is approved. Factoring in both those
additional shares and the 282,660 Common Shares subject to
outstanding awards or available for future awards under the 2012
Plan, the approximate total overhang under the 2012 Plan and the
2022 Plan is 782,660 Common Shares (or approximately 4.1% of the
Common Shares outstanding as of April 18,
2022). However, as noted above, no further grants will
be made under the 2012 Plan upon the effective date of the 2022
Plan.
Based on the closing price on Nasdaq Global Select Market for our
Common Shares on April 18, 2022 of $46.61 per share, the aggregate
market value as of April 18, 2022 of the new 500,000 Common Shares
requested under the 2022 Plan was $23,305,000.
In 2019, 2020 and 2021, awards under the 2012 Plan covered 22,713
shares, 23,207 shares, and 27,388 shares,
respectively. Because the number of shares to be issued
to satisfy our performance-based awards (which are
cash-denominated) is not determinable as of the dates of grant,
these numbers reflect, for each year, the number of shares subject
to time-based awards granted during such year, plus the number of
shares actually earned under performance-based awards during such
year. As a result, based on our basic weighted average
Common Shares outstanding for those fiscal years of 19,248,657,
19,288,966, and 19,322,391, respectively, for the three-fiscal-year
period 2019-2021, our average burn rate, not taking into account
forfeitures, was approximately 0.13% (our individual years’ burn
rates were 0.12% for fiscal 2019, 0.12% for fiscal 2020 and 0.14%
for fiscal 2021).
In determining the number of shares to request for approval under
the 2022 Plan, our management worked with the Compensation
Committee to evaluate a number of factors, including our recent
share usage and criteria expected to be utilized by institutional
proxy advisory firms in evaluating our proposal for the 2022
Plan.
If the 2022 Plan is approved, we intend to utilize the shares
authorized under the 2022 Plan to continue our practice of
incentivizing key individuals through equity grants. We
currently anticipate that the shares requested in connection with
the approval of the 2022 Plan will last for the entire ten-year
life of the 2022 Plan, based on our recent grant rates and the
approximate current share price, but could last for a shorter
period of time if actual practice does not match recent rates or
our share price changes materially. As noted below, our
Compensation Committee retains full discretion under the 2022 Plan
to determine the number and amount of awards to be granted under
the 2022 Plan, subject to the terms of the 2022 Plan, and future
benefits that may be received by participants under the 2022 Plan
are not determinable at this time.
- 9 -
We believe that we have demonstrated a commitment to sound equity
compensation practices in recent years. We recognize
that equity compensation awards dilute shareholders’ equity, so we
have carefully managed our equity incentive
compensation. Our equity compensation practices are
intended to be competitive and consistent with market practices,
and we believe our historical share usage has been responsible and
mindful of shareholder interests, as described above.
In evaluating this proposal, shareholders should consider all of
the information in this proposal.
2022
Plan Highlights
Below are certain highlights of the 2022 Plan. These
features of the 2022 Plan are designed to reinforce alignment
between equity compensation arrangements awarded pursuant to the
2022 Plan and shareholders’ interests, consistent with sound
corporate governance practices.
Reasonable 2022 Plan Limits. Generally, up
to 500,000 Common Shares, plus
the number of
Common Shares that are added (or added back, as applicable) to the
aggregate number of shares available under the 2022 Plan pursuant
to the share counting rules of the 2022 Plan (as described below),
may be issued or transferred pursuant to 2022 Plan
awards. These shares may be shares of original issuance
or treasury shares, or a combination of the
two. Generally, the aggregate number of Common Shares
available for issuance or transfer under the 2022 Plan will be
reduced by one Common Share for every one Common Share issued or
transferred in connection with an award granted under the 2022
Plan. Common Shares covered by an award granted under
the 2022 Plan will not be counted as used unless and until they are
actually issued or transferred to a participant.
Minimum Vesting Requirement. The 2022 Plan
provides for certain minimum vesting periods for awards granted to
participants other than non-employee directors that consist of
restricted shares, restricted share units (“RSUs”), performance
shares, performance units, cash incentive awards and certain other
awards. Specifically, if such an award vests based only
on the passage of time rather than the achievement of management
objectives, the period of time will be no shorter than three years,
except that vesting may occur ratably during the three-year period,
on at least an annual basis, as determined by the
Committee. If an award vests upon the achievement of
management objectives, then such award may not vest sooner than one
year from the date of grant (or, in the case of performance shares,
performance units and cash incentive awards, after a one-year
performance period). Notwithstanding anything in the
2022 Plan to the contrary, up to 10% of the maximum number of
Common Shares that may be issued or transferred under the 2022
Plan, as may be adjusted under the terms of the 2022 Plan, may be
used for (1) awards of restricted shares, RSUs, performance shares,
performance units, cash incentive awards and other awards granted
to participants other than non-employee directors that do not
comply with the applicable three-year or one-year vesting
requirements set forth in the 2022 Plan plus (2) awards granted to
non-employee directors.
Incentive Stock Option Limit. The 2022 Plan
also provides that, subject as applicable to adjustment as
described in the 2022 Plan, the aggregate number of Common Shares
actually issued or transferred upon the exercise of Incentive Stock
Options (as defined below) will not exceed 500,000 Common
Shares.
Limited Share Recycling Provisions. Subject to
certain exceptions described in the 2022 Plan, if any Common Shares
issued or transferred pursuant to an award granted under the 2022
Plan are forfeited, or an award granted under the 2022 Plan (in
whole or in part) is canceled or forfeited, expires, is settled for
cash, or is unearned, the Common Shares issued or transferred
pursuant to, or subject to, such award (as applicable) will, to the
extent of such cancellation, forfeiture, expiration, cash
settlement, or unearned amount, again be available (or continue to
be available) for issuance or transfer under the 2022
Plan. Additionally, if after the effective date of the
2022 Plan, any Common Shares issued or transferred pursuant to an
award granted under the 2012 Plan are forfeited, the Common Shares
subject to such award will, to the extent of such forfeiture, be
available for awards under the 2022 Plan. Further, the
following will reduce the aggregate number of Common Shares
available under the 2022 Plan:
- 10 -
|
•
|
If Common Shares are
withheld by us, tendered or otherwise used in payment of the
exercise price of a stock option granted under the 2022 Plan, the
total number of Common Shares covered by the stock option
being exercised;
|
|
•
|
Common Shares
withheld by us, tendered or otherwise used to satisfy tax
withholding with respect to awards granted under the 2022 Plan;
and
|
|
•
|
Common Shares
subject to a stock appreciation right, to the extent it is
exercised and settled in Common Shares, and whether or not all
Common Shares covered by the stock appreciation right are actually
issued to the participant on exercise.
|
Common Shares reacquired by the Company on the open market or
otherwise using cash proceeds from the exercise of stock options
will not be added to the aggregate number of Common Shares
available for issuance or transfer under the 2022 Plan.
Further, if a participant elects to give up the right to receive
compensation in exchange for Common Shares based on fair market
value, such Common Shares will not count against the aggregate
number of shares available for issuance or transfer under the 2022
Plan.
No Repricing Without Shareholder Approval. Outside of
certain corporate transactions or adjustment events described in
the 2022 Plan or in connection with a “change in control,” the
exercise or base price of stock options and stock appreciation
rights (“SARs”) cannot be reduced, nor can “underwater” stock
options or SARs be cancelled in exchange for cash or replaced with
other awards with a lower exercise or base price, without
shareholder approval under the 2022 Plan.
Change in Control Definition. The 2022 Plan
includes a non-liberal definition of “change in control,” which is
described below.
Exercise or Base Price Limitation. Except with
respect to certain converted, assumed or substituted awards as
described in the 2022 Plan, no stock options or SARs will be
granted with an exercise or base price less than the fair market
value of a Common Share on the date of grant.
Clawback Provisions. The 2022 Plan
includes clawback provisions, as described below.
Summary of Other
Material Terms of the 2022 Plan
Administration. The 2022 Plan
will generally be administered by the Compensation Committee (or
its successor), or any other committee of the Board of Directors
designated by the Board of Directors to administer the 2022
Plan. However, at the discretion of the Board of
Directors, the 2022 Plan may be administered by the Board of
Directors, including with respect to the administration of any
responsibilities and duties held by the Compensation Committee
under the 2022 Plan. References to the “Committee” in
this proposal refer to the Compensation Committee, such other
committee designated by the Board of Directors, or the Board of
Directors, as applicable. Subject to applicable law, the
Committee may delegate certain administrative duties to officers,
agents or advisors. In addition, the Committee may by
resolution, subject to certain restrictions set forth in the 2022
Plan, authorize one or more officers of the Company to (1)
designate employees to be recipients of awards under the 2022 Plan,
and (2) determine the size of such awards. However, the
Committee may not delegate such responsibilities to officers for
awards granted to non-employee directors or certain employees who
are subject to the reporting requirements of Section 16 of the
Exchange Act of 1934.
Eligibility. Any person who
is selected by the Committee to receive benefits under the 2022
Plan and who is at that time an officer or other employee of the
Company or any of its subsidiaries (including a person who has
agreed to commence serving in such capacity within 90 days of the
date of grant) is eligible to participate in the 2022
Plan. In addition, persons (including consultants) who
provide services to the Company or any of its subsidiaries that are
equivalent to those typically provided by an employee (provided
that such persons satisfy the Form S-8 definition of “employee”),
and non-employee
- 11 -
directors of
the Company, may also be selected by the Committee to participate
in the 2022 Plan. As of April 18, 2022, the Company and its
subsidiaries had approximately 377 employees,
and the Company
had 8 non-employee
directors. Although consultants of the
Company and its subsidiaries are eligible to participate in the
2022 Plan, we have not granted equity awards to consultants in
recent years and, due to the temporary status
of such service providers, do not have a current estimate of how
many such consultants may be eligible in the future to participate
in the 2022 Plan. We do not currently expect to make material
grants of awards under the 2022 Plan to consultants.
The basis for
participation in the 2022 Plan by eligible persons is the selection
of such persons by the Committee (or its authorized delegate) in
its discretion.
Evidence of Awards. Generally, each
grant of an award under the 2022 Plan will be evidenced by an award
agreement, certificate, resolution or other type or form of writing
or other evidence approved by the Committee (an “Evidence of
Award”), which will contain such terms and provisions as the
Committee may determine, consistent with the 2022 Plan.
Treatment of Awards on Termination or Change in Control. Awards under
the 2022 Plan may be subject to service-based vesting requirements,
and the Committee may specify management objectives regarding the
vesting of such awards. However, such awards may provide
for continued vesting or earlier vesting (1) in the event of the
retirement, death or disability of a participant or (2) in the
event of a change in control where either (A) within a specified
period the participant is involuntarily terminated for reasons
other than for “cause” or terminates his or her employment for
“good reason” (as such terms may be defined in the Evidence of
Award or otherwise) or (B) the award is not assumed or converted
into replacement awards in a manner described in the Evidence of
Award.
Types of Awards Under the 2022 Plan. Pursuant to
the 2022 Plan, the Company may grant cash awards and restricted
shares, RSUs, stock options (including stock options intended to be
“incentive stock options” as defined in Section 422 of the Code
(“Incentive Stock Options”)), SARs, performance shares, performance
units, cash incentive awards, and certain other awards based on or
related to our Common Shares. A brief description of the
types of awards which may be granted under the 2022 Plan is set
forth below.
Restricted Shares. Restricted
shares constitute an immediate transfer of the ownership of Common
Shares to the participant in consideration of the performance of
services, entitling such participant to dividend, voting and other
ownership rights, subject to the substantial risk of forfeiture and
restrictions on transfer determined by the
Committee. Each such grant or sale of restricted shares
may be made without additional consideration or in consideration of
a payment by the participant that is less than the fair market
value per Common Share on the date of grant. Any grant
of restricted shares may require that any and all dividends or
distributions paid on restricted shares that remain subject to a
substantial risk of forfeiture be automatically deferred and/or
reinvested in additional restricted shares, which will be subject
to the same restrictions as the underlying restricted
shares. Any such dividends or other distributions on
restricted shares will be deferred until, and paid contingent upon,
the vesting of such restricted shares.
RSUs. RSUs awarded
under the 2022 Plan constitute an agreement by the Company to
deliver Common Shares, cash, or a combination of the two, to the
participant in the future in consideration of the performance of
services, but subject to the fulfillment of such conditions during
the restriction period as the Committee may
specify. Each grant or sale of RSUs may be made without
additional consideration or in consideration of a payment by the
participant that is less than the fair market value of our Common
Shares on the date of grant. During the restriction
period applicable to RSUs, the participant will have no right to
transfer any rights under the award and will have no rights of
ownership in the Common Shares deliverable upon payment of the RSUs
and no right to vote them. The Committee may, at or
after the date of grant, authorize the payment of dividend
equivalents on such RSUs on a deferred and contingent basis, either
in cash or in additional Common Shares. However,
dividend equivalents or other distributions on Common Shares
underlying RSUs will be deferred until, and paid contingent upon,
the vesting of such RSUs. Each grant or sale of RSUs
will specify the time and manner of payment of the
- 12 -
RSUs that have
been earned. An RSU may be paid in cash, Common
Shares
or any
combination of the two.
Stock Options. A stock option
is a right to purchase Common Shares upon exercise of the stock
option. Stock options granted to an employee under the
2022 Plan may consist of either an Incentive Stock Option, a
non-qualified stock option that is not intended to be an “incentive
stock option” under Section 422 of the Code, or a combination of
both. Each grant will specify whether the consideration
to be paid in satisfaction of the exercise price will be payable:
(1) in cash, by check acceptable to the Company, or by wire
transfer of immediately available funds; (2) by the actual or
constructive transfer to the Company of Common Shares owned by the
participant with a value at the time of exercise that is equal to
the total exercise price; (3) subject to any conditions or
limitations established by the Committee, by a net exercise
arrangement pursuant to which the Company will withhold Common
Shares otherwise issuable upon exercise of a stock option; (4) by a
combination of the foregoing methods; or (5) by such other methods
as may be approved by the Committee. To the extent
permitted by law, any grant may provide for deferred payment of the
exercise price from the proceeds of a sale through a bank or broker
of some or all of the shares to which the exercise
relates. Stock options granted under the 2022 Plan may
not provide for dividends or dividend equivalents.
SARs. A SAR is a
right to receive from us an amount equal to 100%, or such lesser
percentage as the Committee may determine, of the spread between
the base price of the SAR and the value of our Common Shares on the
date of exercise. A SAR may be paid in cash, Common
Shares or any combination of the two. SARs granted under
the 2022 Plan may not provide for dividends or dividend
equivalents.
Stock Option and SAR Expiration. The term of a
stock option or SAR may not extend more than 10 years from the date
of grant, and the Committee may provide in an Evidence of Award for
the automatic exercise of a stock option or
SAR.
Performance Shares, Performance Units and Cash Incentive
Awards. A performance
share is a bookkeeping entry that records the equivalent of one
Common Share, and a performance unit is a bookkeeping entry that
records a unit equivalent to $1.00 or such other value as
determined by the Committee. Each grant of a cash
incentive award, performance shares or performance units will
specify the number or amount of performance shares or performance
units, or the amount payable with respect to a cash incentive award
being awarded, which number or amount may be subject to adjustment
to reflect changes in compensation or other
factors. Each grant will specify management objectives
regarding the earning of the award. Each grant will
specify the time and manner of payment of performance shares,
performance units or a cash incentive award that has been
earned.
Any grant of performance shares or performance units may provide
for the payment of dividend equivalents in cash or in additional
Common Shares, subject to deferral and payment on a contingent
basis based on the participant’s earning and vesting of the
performance shares or performance units, as applicable, with
respect to which such dividend equivalents are paid.
Awards to Non-Employee Directors. Subject to the
applicable limits set forth in the 2022 Plan, the Committee may,
from time to time and upon such terms and conditions as it may
determine, authorize the granting to non-employee directors of
stock options, SARs or Other Awards (as defined below) and may also
authorize the grant or sale of Common Shares, restricted shares or
RSUs to non-employee directors. Each grant of an award to a
non-employee director will be upon such terms and conditions as
approved by the Committee, will not be subject to any minimum
vesting period, and will be evidenced by an Evidence of Award in
such form as will be approved by the Committee. Each stock option
and SAR granted under the 2022 Plan to a non-employee director will
expire not more than 10 years from the date of grant. If a
non-employee director subsequently becomes an employee of the
Company or a subsidiary of the Company while remaining a member of
the Board, any award held under the 2022 Plan by such individual at
the time of such commencement of employment will not be affected
thereby. Non-employee directors may be awarded, or may be permitted
to elect to receive, pursuant to procedures established
by
- 13 -
the Board, all
or any portion of their annual retainer, meeting fees or other fees
in Common Shares, Restricted shares, RSUs or other awards under the
2022 Plan in lieu of cash.
Other Awards. Subject to
applicable law and applicable share limits under the 2022 Plan, the
Committee may grant to any participant Common Shares or such other
awards (“Other Awards”) that may be denominated or payable in,
valued in whole or in part by reference to, or otherwise based on,
or related to, Common Shares or factors that may influence the
value of such Common Shares, as further described in the 2022
Plan. The terms and conditions of any such awards will
be determined by the Committee. In addition, the
Committee may grant cash awards, as an element of or supplement to
any other awards granted under the 2022 Plan. The
Committee may also authorize the grant of Common Shares as a bonus,
or may authorize the grant of Other Awards in lieu of obligations
of the Company or a subsidiary to pay cash or deliver other
property under the 2022 Plan or under other plans or compensatory
arrangements, subject to terms determined by the Committee in a
manner that complies with Section 409A of the Code.
The Committee may provide for the payment of dividends or dividend
equivalents on Other Awards on a deferred and contingent basis,
either in cash or in additional Common Shares. However,
dividend equivalents or other distributions on Common Shares
underlying Other Awards will be deterred until, and paid contingent
upon, the earning and vesting of such awards.
Change in Control. The 2022 Plan
includes a definition of “change in control.” In
general, except as may be otherwise prescribed by the Committee in
an Evidence of Award, a change in control will be deemed to have
occurred upon the occurrence (after the effective date of the 2022
Plan) of any of the following events (subject to certain exceptions
and limitations and as further described in the 2022
Plan): (1) the acquisition by any person or entity of
beneficial ownership of 35% or more of the then outstanding
securities of the Company entitled to vote generally in the
election of directors; (2) a majority of the Board ceases to be
comprised of incumbent directors (as defined in the 2022 Plan); (3)
the consummation of a reorganization, merger or consolidation, a
sale or other disposition of all or substantially all of the assets
of the Company or other transaction that results in a substantial
change in the ownership or leadership of the Company (as further
described in the 2022 Plan); or (4) approval by our shareholders of
a complete liquidation or dissolution of the Company, except as
otherwise provided in the 2022 Plan.
Management Objectives. The 2022 Plan
generally provides that any of the awards set forth above may be
granted subject to the achievement of specified management
objectives. Management objectives are defined as the
performance objective(s) established pursuant to the 2022 Plan for
applicable awards. The management objectives applicable
to an award under the 2022 Plan (if any) will be determined by the
Committee, and may be based on one or more, or a combination, of
metrics under the following categories or such other metrics as may
be determined by the Committee (including relative or growth
achievement regarding such metrics): (1) cash flow/net
assets ratio; (2) return on assets, capital or investment; (3)
return on equity; (4) earnings per share growth; (5) revenue
growth; (6) total shareholder return; (7) loss ratio; (8) expense
ratio; (9) combined ratio; (10) direct premiums written or premium
volume; (11) net income (before or after taxes); (12) earnings
before all or any interest, taxes, depreciation and/or amortization
(“EBIT”, “EBITA” or “EBITDA”); (13) market share; (14) cost
reduction goals; (15) earnings from continuing operations; (16)
levels of expense, costs or liabilities; (17) operating profit;
(18) sales or revenues; (19) stock price appreciation; or (20)
implementation or completion of critical projects or
processes.
If the Committee determines that a change in the business,
operations, corporate structure or capital structure of the
Company, or the manner in which it conducts its business, or other
events or circumstances render the management objectives
unsuitable, the Committee may in its discretion modify such
management objectives or the goals or actual levels of achievement,
in whole or in part, as the Committee deems appropriate and
equitable.
Transferability of Awards. Except as
otherwise provided by the Committee, and subject to the terms of
the 2022 Plan with respect to Section 409A of the Code, no awards
under the 2022 Plan will be
- 14 -
transferrable
by a participant except by will or the laws of descent and
distribution. In no event will any such award granted
under the 2022 Plan be transferred for value.
Adjustments; Corporate Transactions. The Committee
will make or provide for such adjustments in: (1) if applicable,
the number of and kind of Common Shares covered by awards under the
2022 Plan; (2) the exercise price or base price provided in
outstanding stock options and SARs, respectively; (3) cash
incentive awards; and (4) other award terms, as the Committee in
its sole discretion, determines in good faith is equitably required
in order to prevent dilution or enlargement of the rights of
participants that otherwise would result from (a) any extraordinary
cash dividend, stock dividend, stock split, combination of shares,
recapitalization or other change in the capital structure of the
Company; (b) any merger, consolidation, spin-off, spin-out,
split-off, split-up, reorganization, partial or complete
liquidation or other distribution of assets, issuance of rights or
warrants to purchase securities; or (c) any other corporate
transaction or event having an effect similar to any of the
foregoing.
In the event of any such transaction or event, or in the event of a
change in control of the Company, the Committee may provide in
substitution for any or all outstanding awards under the 2022 Plan
such alternative consideration (including cash), if any, as it may
in good faith determine to be equitable under the circumstances and
will require the surrender of all awards so replaced in a manner
that complies with Section 409A of the Code. In
addition, for each stock option or SAR with an exercise price or
base price, respectively, greater than the consideration offered in
connection with any such transaction or event or change in control
of the Company, the Committee may cancel such stock option or SAR
without any payment to the person holding such stock option or
SAR. The Committee will make or provide for such
adjustments to the number of Common Shares available under the 2022
Plan and the share limits of the 2022 Plan as the Committee, in its
sole discretion, determines in good faith is appropriate to reflect
such transaction or event, subject to certain tax-based
limitations.
Detrimental Activity and Recapture. Any Evidence
of Award may reference a clawback policy of the Company or provide
for the cancellation or forfeiture of an award or forfeiture and
repayment to us of any gain related to an award, or other
provisions intended to have a similar effect, upon such terms and
conditions as may be determined by the Committee from time to time,
if any participant, either during employment or other service with
us or a subsidiary or within a specified period after such
employment or service, engages in any detrimental activity as
described in the 2022 Plan, in the applicable Evidence of Award or
in such clawback policy. In addition, any Evidence of
Award or such clawback policy may provide for cancellation or
forfeiture of an award or the forfeiture and repayment of any
Common Shares issued under and/or any other benefit related to an
award, or other provisions intended to have a similar effect,
including upon such terms and conditions as may be required by the
Committee or under Section 10D of the Exchange Act and any
applicable rules and regulations promulgated by the Securities and
Exchange Commission or any national securities exchange or national
securities association on which the Common Shares may be
traded.
Withholding. To the extent
the Company is required to withhold federal, state, local or
foreign taxes or other amounts in connection with any payment made
or benefit realized by a participant or other person under the 2022
Plan, and the amounts available to us for such withholding are
insufficient, it will be a condition to the receipt of such payment
or the realization of such benefit that the participant or such
other person make arrangements satisfactory to the Company for
payment of the balance of such taxes or other amounts required to
be withheld, which arrangements, in the discretion of the
Committee, may include relinquishment of a portion of such
benefit. If a participant’s benefit is to be received in
the form of Common Shares, and such participant fails to make
arrangements for the payment of taxes or other amounts, then,
unless otherwise determined by the Committee, we will withhold
Common Shares having a value equal to the amount required to be
withheld. When a participant is required to pay the
Company an amount required to be withheld under applicable income,
employment, tax or other laws, the Committee may require the
participant to satisfy the obligation, in whole or in part, by
having withheld, from the shares delivered or required to be
delivered to the participant, Common Shares having a value equal to
the amount required to be withheld or by delivering to us other
Common Shares held by such participant. The Common
Shares used for tax or other withholding will be valued at an
amount equal to the fair market value of such Common Shares on the
date the benefit is to be included in the participant’s
- 15 -
income. In no
event will the fair market value of the Common Shares to be
withheld and delivered pursuant to the 2022 Plan exceed the minimum
amount required to be withheld, unless (1) an additional amount can
be withheld and not result in adverse accounting consequences, and
(2) such additional withholding amount is authorized by the
Committee.
Amendment and Termination of the 2022 Plan. The Board of
Directors generally may amend the 2022 Plan from time to time in
whole or in part, subject to shareholder approval in certain
circumstances as required under the 2022 Plan, applicable law, or
stock exchange rules.
Further, subject to the 2022 Plan’s prohibition on repricing, the
Committee generally may amend the terms of any award prospectively
or retroactively, subject in certain circumstances to participant
consent. If permitted by Section 409A of the Code and
subject to certain other limitations set forth in the 2022 Plan,
and including in the case of termination of employment or service,
or in the case of unforeseeable emergency or other circumstances or
in the event of a change in control, the Committee may provide for
continued vesting or accelerate the vesting of certain awards
granted under the 2022 Plan or waive any other limitation or
requirement under any such award.
The Board of Directors may, in its discretion, terminate the 2022
Plan at any time. Termination of the 2022 Plan will not
affect the rights of participants or their successors under any
awards outstanding and not exercised in full on the date of
termination. No grant will be made under the 2022 Plan
on or after the tenth anniversary of the effective date of the 2022
Plan, but all grants made prior to such date will continue in
effect thereafter subject to their terms and the terms of the 2022
Plan.
Allowances for Conversion Awards and Assumed Plans. Common Shares
issued or transferred under awards granted under the 2022 Plan in
substitution for or conversion of, or in connection with an
assumption of, restricted shares, RSUs, stock options, SARs or
other share or share-based awards held by awardees of an entity
engaging in a corporate acquisition or merger transaction with us
or any of our subsidiaries will not count against (or be added to)
the aggregate share limit or other 2022 Plan limits described
above. Additionally, shares available under certain
plans that we or our subsidiaries may assume in connection with
corporate transactions from another entity may be available for
certain awards under the 2022 Plan, under circumstances further
described in the 2022 Plan, but will not count against the
aggregate share limit or other 2022 Plan limits described
above.
New
Plan Benefits
It is not possible to determine the specific amounts and types of
awards that may be awarded in the future under the 2022 Plan
because the grant and actual settlement of awards under the 2022
Plan are subject to the discretion of the plan administrator.
U.S.
Federal Income Tax Consequences
The following is a brief summary of certain of the Federal income
tax consequences of certain transactions under the 2022 Plan based
on Federal income tax laws in effect. This summary,
which is presented for the information of shareholders considering
how to vote on this proposal and not for 2022 Plan participants, is
not intended to be complete and does not describe Federal taxes
other than income taxes (such as Medicare and Social Security
taxes), or state, local or foreign tax consequences.
Tax
Consequences to Participants
Restricted Shares. The
recipient of restricted shares generally will be subject to tax at
ordinary income rates on the fair market value of the restricted
shares (reduced by any amount paid by the recipient) at such time
as the restricted shares are no longer subject to forfeiture or
restrictions on transfer for purposes of Section 83 of the
Code. However, a recipient who so elects under Section
83(b) of the Code within 30 days of the date of transfer of the
shares will generally have taxable ordinary income on the date of
transfer of the shares equal to the excess of the fair market value
of such shares over any purchase price.
- 16 -
RSUs, Performance Shares, Performance Units, and Cash Incentive
Awards. No
income generally will be recognized upon the grant of RSUs,
performance shares, performance units or cash incentive
awards. Upon payment in respect of such awards, the
recipient generally will be required to include as taxable ordinary
income in the year of receipt an amount equal to the amount of cash
received and the fair market value of any unrestricted Common
Shares received (reduced by any amount paid by the
recipient).
Nonqualified Stock Options and SARs. In general:
|
•
|
no income will be
recognized by a grantee at the time a non-qualified stock option or
SAR is granted; and
|
|
•
|
at the time of
exercise of a non-qualified stock option or SAR, ordinary income
will be recognized by the grantee in an amount equal to, in the
case of a non-qualified stock option, the difference between the
option price paid for the shares and the fair market value of the
unrestricted shares on the date of exercise and, in the case of a
SAR, the amount of cash received and the fair market value of any
unrestricted shares received.
|
Incentive Stock Options. No income
generally will be recognized by an optionee upon the grant or
exercise of an “incentive stock option” as defined in Section 422
of the Code. If Common Shares are issued to the optionee
pursuant to the exercise of an incentive stock option, and if no
disqualifying disposition of such shares is made by such optionee
within two years after the date of grant or within one year after
the transfer of such shares to the optionee, then upon sale of such
shares, any amount realized in excess of the option price will be
taxed to the optionee as a long-term capital gain and any loss
sustained will be a long-term capital loss.
If Common Shares acquired upon the exercise of an incentive stock
option are disposed of prior to the expiration of either holding
period described above, the optionee generally will recognize
ordinary income in the year of disposition in an amount equal to
the excess (if any) of the fair market value of such shares at the
time of exercise (or, if less, the amount realized on the
disposition of such shares if a sale or exchange) over the exercise
price paid for such shares. Any further gain (or loss)
realized by the participant generally will be taxed as short-term
or long-term capital gain (or loss) depending on the holding
period.
Tax
Consequences to the Company and its Subsidiaries
To the extent that a participant recognizes ordinary income in the
circumstances described above, the Company or the subsidiary for
which the participant performs services will be entitled to a
corresponding deduction provided that, among other things, it is
not disallowed by the $1 million limitation on certain executive
compensation under Section 162(m) of the Code.
Registration with
the SEC
We intend to file a Registration Statement on Form S-8 relating to
the issuance of Common Shares under the 2022 Plan with the
Securities and Exchange Commission pursuant to the Securities Act
of 1933, as amended, as soon as practicable after approval of the
2022 Plan by our shareholders.
Vote
Required
The affirmative vote of a majority of the holders of our common
shares entitled to vote and present at the Annual Meeting is
required to approve the 2022 Plan. Accordingly, abstentions will
have the effect of a vote against this proposal. Broker
non-votes will not have any effect on the adoption of this
proposal.
The Board recommends a vote “FOR” the approval of the 2022
Plan.
- 17 -
PROPOSAL
3
ADVISORY VOTE ON EXECUTIVE COMPENSATION
Pursuant to Section 14A of the Securities Exchange Act of 1934
(the “Exchange Act”), we are submitting the compensation of our
executive officers as disclosed in this proxy statement to our
shareholders for an advisory vote. Our Board has adopted a policy
to hold annual advisory votes on executive compensation. Our next
advisory vote on the frequency of shareholder votes on executive
compensation will take place at our annual meeting of shareholders
in 2023.
We encourage shareholders to review the information regarding our
compensation practices and decisions as described below under the
heading “Compensation Discussion
and Analysis.” We seek to offer our employees, including our
named executive officers, a competitive pay package that rewards
individual contributions, performance and experience with our
Company, while aligning the interests of our executive officers and
other key employees with those of the Company’s shareholders. The
Compensation Committee sets compensation in this manner to ensure
that our compensation practices do not put the Company at a
disadvantage in attracting and retaining executives and other
employees, while also ensuring a competitive cost structure for our
Company.
The vote on this proposal is not intended to address any specific
element of compensation. Rather, the vote relates to the
compensation of our executive officers, as described under the
headings “Compensation Discussion and Analysis” and “Executive
Compensation” in this proxy statement. The vote is advisory, which
means that the vote is not binding on the Company, our Board of
Directors or the Compensation Committee. However, the Compensation
Committee expects to consider the outcome of this advisory vote in
evaluating whether any actions are appropriate with respect to our
compensation programs for our executive officers.
The Board recommends a vote “FOR” the approval of the compensation
of our named executive officers.
- 18 -
PROPOSAL
4
RATIFICATION OF APPOINTMENT OF
ERNST & YOUNG LLP AS THE COMPANY’S INDEPENDENT
REGISTERED PUBLIC ACCOUNTING FIRM FOR 2022
The Audit Committee has appointed Ernst & Young LLP as the
Company’s independent registered public accounting firm for 2022.
The Board is asking shareholders to ratify this appointment. SEC
regulations and the Nasdaq listing requirements require the
Company’s independent registered public accounting firm to be
engaged, retained and supervised by the Audit Committee. However,
the Board considers the selection of an independent registered
public accounting firm to be an important matter to shareholders.
Accordingly, the Board considers a proposal for shareholders to
ratify this appointment to be an opportunity for shareholders to
provide input to the Audit Committee and the Board on a key
corporate governance issue.
Representatives of Ernst & Young LLP are expected to be
present at the Annual Meeting and will be offered the opportunity
to make a statement if they so desire. They will also be available
to respond to appropriate questions. For additional information
regarding our independent registered public accounting firm, see
“Independent Public
Accountants.”
The Board recommends a vote “FOR” the ratification of
Ernst & Young LLP
as the Company’s independent registered public accounting firm.
- 19 -
Corporate
governance
and board information
Board of Directors
The Board presently consists of eight non-employee directors and
one employee director. The Board is divided into three classes,
with each class serving three-year terms. The term of one class
expires at each annual meeting of shareholders.
Director Compensation
The elements of compensation payable to our non-employee directors
in 2021 are briefly described below.
Board Service:
|
|
|
|
|
Annual cash retainer
|
|
$
|
50,000
|
|
Annual restricted stock award
|
|
|
50,000
|
|
Board Committee Service:
|
|
|
|
|
Chairman annual retainer
|
|
$
|
45,000
|
|
Audit Committee Chair annual cash retainer
|
|
|
20,000
|
|
Compensation Committee Chair annual cash retainer
|
|
|
17,500
|
|
Nominating and Corporate Governance Committee Chair annual cash
retainer
|
|
|
12,500
|
|
Risk Committee Chair annual cash retainer
|
|
|
12,500
|
|
Committee member annual cash retainer
|
|
|
5,000
|
|
Committee Chairs do not receive annual cash retainers for being
members of the committees they chair. Directors do not receive
additional compensation for serving on our Risk Committee. The
Company reimburses directors for reasonable out-of-pocket expenses
incurred in connection with their service as directors. Any
director who is an employee of the Company does not receive
additional compensation for serving as a director.
The amount of restricted stock granted to each non-employee
director is equal to $50,000 divided by the closing price of our
common stock on the date of the annual meeting of shareholders at
which the non-employee director is elected or continues to be a
member of the Board. The shares of restricted stock granted to
non-employee directors vest at the next annual meeting of
shareholders. If a non-employee director is first elected or
appointed to the Board at a time other than at an annual meeting of
shareholders, the non-employee director is awarded a prorated
initial restricted stock grant at that time. Awards to non-employee
directors are made under the Director Plan.
On June 11, 2021, each non-employee director was granted 801
shares of restricted stock.
The following table provides information regarding the compensation
of our non-employee directors for the year ended December 31,
2021.
Name
|
|
Fees Earned or
Paid in Cash
|
|
|
Stock
Awards (1)
|
|
|
Total
|
|
Michael J. Brown
|
|
$
|
72,500
|
|
|
$
|
49,982
|
|
|
$
|
122,482
|
|
Teri G. Fontenot
|
|
|
60,000
|
|
|
|
49,982
|
|
|
|
109,982
|
|
Philip A. Garcia
|
|
|
75,000
|
|
|
|
49,982
|
|
|
|
124,982
|
|
Billy B. Greer (2)
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Jared A. Morris
|
|
|
110,000
|
|
|
|
49,982
|
|
|
|
159,982
|
|
Millard E. Morris
|
|
|
62,500
|
|
|
|
49,982
|
|
|
|
112,482
|
|
Randall E. Roach
|
|
|
67,500
|
|
|
|
49,982
|
|
|
|
117,482
|
|
Sean M. Traynor
|
|
|
60,000
|
|
|
|
49,982
|
|
|
|
109,982
|
|
__________
1.
|
The
grant date fair value of each award, calculated in accordance with
Financial Accounting Standards Board (“FASB”) Accounting Standards
Codification (“ASC”) Topic 718 (“Topic 718”), was $49,982. Pursuant
to SEC rules, the amounts shown in this column exclude the impact
of estimated forfeitures related to service-based vesting
conditions. See Note 12 to our consolidated
|
- 20 -
|
financial
statements included in our Annual Report on Form 10-K for the year
ended December
31, 2021
for
information regarding the assumptions made in determining these
values. As of December 31,
2021,
each non-employee director held
801
shares of
restricted stock.
|
2.
|
Mr.
Greer became a director on March 15, 2022. He received a prorated
award of 261 shares of restricted stock, when he joined the Board
on March 15, 2022.
|
Non-Employee Director Stock Ownership and Retention Guidelines
Our Board recognizes that ownership of common stock is an effective
means to align the interests of our directors with those of our
shareholders. The following is a summary of our stock ownership and
retention guidelines for our non-employee directors.
Non-Employee Director Stock Ownership Guidelines. Non-employee directors
are expected to acquire and hold during their Board service shares
of our common stock equal in value to at least three times the
annual cash retainer paid to our directors, or $150,000.
Non-employee directors have five years from their initial election
to the Board to meet these ownership guidelines.
Non-Employee Director Retention Guidelines. Directors are expected to
continuously own sufficient shares to meet the guidelines once
attained. Until a director meets the ownership guidelines, the
director will be required to hold 75% of the shares of common stock
received from any equity award, net of any shares used to pay the
tax withholding. If a director attains compliance with the stock
ownership guideline and subsequently falls below the guideline
because of a decrease in the price of our common stock, the
director will be deemed in compliance provided that the director
retains the shares then held.
The following table provides the equity ownership of each of our
non-employee directors as of December 31, 2021, measured in
dollars. Ownership was calculated based on a price of $53.83 per
share, the closing price of the Company’s common stock on December
31, 2021, the last trading day of the year.
Non-Employee Director
|
|
Total Ownership
|
|
Michael J. Brown
|
|
$
|
331,647
|
|
Teri G. Fontenot
|
|
$
|
291,113
|
|
Billy B. Greer (1)
|
|
$
|
—
|
|
Philip A. Garcia
|
|
$
|
1,003,553
|
|
Jared A. Morris
|
|
$
|
4,133,714
|
|
Millard E. Morris
|
|
$
|
5,955,805
|
|
Randall E. Roach
|
|
$
|
552,403
|
|
Sean M. Traynor
|
|
$
|
523,551
|
|
__________
1.
|
Mr.
Greer became a director on March 15, 2022. Under the guidelines,
Mr. Greer has until March 15, 2027 to meet the ownership
guidelines.
|
Corporate Governance
The Board and senior management of the Company believe that one of
their primary responsibilities is to promote a corporate culture of
accountability, responsibility and ethical conduct throughout the
Company. Consistent with these principles, the Company has, among
other things, adopted:
|
•
|
corporate governance guidelines that describe the principles under
which the Board operates;
|
|
•
|
a code of business conduct and ethics applicable to all
employees;
|
|
•
|
written charters for each of its standing committees;
|
|
•
|
a majority voting and director resignation policy that requires any
director nominee who receives a greater number of votes “withheld”
or “against” his or her election than votes “for” his or her
election to tender his or her resignation as a director;
|
- 21 -
|
•
|
a
clawback
policy regarding the recovery of incentive compensation in the
event of a restatement of the Company’s financial statements filed
with the SEC or any state
authority;
|
|
•
|
policies prohibiting our directors, executive officers and
employees from hedging or pledging our common stock;
|
|
•
|
a policy regarding Rule 10b5-1 trading plans requiring, among other
things, that each plan be approved by the Company’s Chief
Compliance Officer and provided to the Chair of the Nominating and
Corporate Governance Committee, or NCG Committee, for review prior
to approval; each plan must provide for a minimum 30-day waiting
period between the execution of the plan and the initial trade
under the plan;
|
|
•
|
a conflict of interest policy applicable to all employees; and
|
|
•
|
a policy regarding related party transaction oversight and
approval.
|
Our corporate governance guidelines, code of business conduct and
ethics, committee charters, majority voting and director
resignation policy and certain other governance policies are
available on the Company’s website (www.amerisafe.com) in the Investors
section. Copies of these documents are also available upon written
request to the Company’s Secretary. The Company will post
information regarding any amendment to, or waiver from, its code of
business conduct and ethics on its website in the Investor
Relations section.
Management regularly meets with shareholders and potential
investors. In those meetings, investors and shareholders express
their views regarding the Company’s executive compensation
practices and corporate governance policies. Management reports to
the Board and the NCG Committee regarding the discussions at these
meetings. The NCG Committee and the Board periodically review the
Company’s corporate governance policies and practices. Based on
these reviews, input from shareholders and recommendations from the
NCG Committee, the Board adopts changes to policies and practices
that it believes are in the best interests of the Company,
including complying with any new SEC or Nasdaq listing
requirements.
The NCG Committee intends to continue to periodically review the
Company’s corporate governance policies, taking into consideration,
among other things, the views of our shareholders and developments
in the governance practices of other public companies.
Corporate
Responsibility
AMERISAFE is defined by its corporate culture of helping to provide
security for employers and their injured employees through the
insurance coverage and services we offer, by paying claims to
injured workers promptly and fairly during their time of need, by
encouraging and supporting our employees to be actively engaged in
the communities in which they live, investing in our employees and
minimizing the impact we have on the environment. AMERISAFE manages
its business with the goal of responsibly delivering long-term
value to all of the Company’s stakeholders by adhering to the
philosophy that good stewardship is good business.
During 2021, we expanded the responsibilities of our Nominating and
Corporate Governance and Compensation Committees to formalize the
Board’s oversight of environmental and social
matters. Our Nominating and Corporate Governance
Committee is primarily responsible for oversight of the Company’s
policies and disclosures related to environmental, safety,
corporate social responsibility, and corporate governance matters
and coordinates with the Risk committee with respect to such risks
as appropriate. Our Compensation Committee is responsible for
oversight of human capital and diversity, equity, and inclusion
matters. We also published initial sustainability disclosure on our
website aligned with both the Sustainability Accounting Standards
Board (SASB) Insurance Industry Standard and the Task Force on
Climate-related Financial Disclosure (TCFD) framework. Below are
highlights regarding our sustainability practices. We
also encourage shareholders to visit the Sustainability section of
our website (www.amerisafe.com)
to view our SASB and TCFD disclosures. We intend to
publish additional sustainability information on our website prior
to our 2023 annual meeting.
- 22 -
Diversity, Equity and Inclusion. With the support of our
Board of Directors, we are committed to enhancing diversity at
AMERISAFE. We strive to promote inclusion through our Company
values and behaviors, and aim to lead by example. Two of
our nine directors are women, one director is African American and
one director is Hispanic. Approximately 64% of our current
workforce is female and 36% male. Women represent 54% of
AMERISAFE’s leadership (defined as vice president level and above),
including our CEO. In terms of racial and ethnic diversity, we
believe our workforce and board demographics are representative of
our geographic location, but we remain focused on enhancing our
diversity, equity and inclusion strategy. To that end, we completed
a workforce assessment in 2021 to identify areas where we can
further progress.
Environmental, Social, and Governance Factors In Investment
Management Strategies. We are heavily regulated,
and our investment policy statement must comply with applicable
laws. Our Board is aware of the value in integrating ESG into our
investment policy and will work with our management-level
Investment Committee to evaluate and develop any such
considerations into its existing investment policy. We also are
discussing potential social-oriented metrics that could be used in
our screening process for municipal bonds.
Environmental. As a monoline workers
compensation insurer, we do not have the same exposure to
weather-related events as property and casualty insurers.
Currently, our Enterprise Risk Management program, led by our Chief
Risk Officer, assesses climate-related risks in terms of the
potential impact on the industries of our policyholders and their
employees. However, we focus on high risk industries; therefore, we
recognize the need to take into account certain geographic metrics
in assessing our exposure to climate related factors as they affect
the risks we insure.
In addition, we recognize we are exposed to operational risk in
light of our Louisiana headquarters location, and have an internal
disaster recovery plan in place to mitigate such risk.
We seek opportunities to capture environmental efficiencies.
Starting early in the 2000’s, AMERISAFE initiated a program to
reduce the use and storage of paper and focus on migrating our
records to electronic form. Almost all Company records are now
stored electronically. This has decreased our usage of paper and
ink, increased efficiency, and saved money for the Company.
Additionally, the Company is focused on recycling of paper,
cardboard, plastic bottles, aluminum cans and batteries. The
Company is also replacing existing florescent and incandescent
lighting with LED lights, as well as improved systems that monitor
heating and air conditioning, to reduce energy consumption and save
costs.
The Communities We Serve. We actively engage and
support local communities through agencies such as United Way, the
Community Foundation of Southwest Louisiana and the Southwest
Louisiana Economic Development Alliance. The Company supports
numerous other charitable and social organizations in the
communities in which we operate. To encourage a culture of giving
back to the communities in which we operate, the Company allows all
employees paid time off for volunteer activities.
Protecting the People We Serve. Protecting the people we
serve is what matters most. We employ Field Safety Professionals or
FSPs with first-hand experience in the industries that we write.
With FSPs deployed around the country, we strive to ensure that
workers are safe by providing a clear observation of safety
practices with verbal and written recommendations for improvement.
Even prior to underwriting a policy, we conduct thorough safety
inspections that focus on a policyholder’s operations, loss
exposures and existing safety controls to prevent potential losses.
Our inspections consider employee experience, turnover, training,
previous loss history and corrective actions, workplace conditions,
equipment conditions and the use of fall protection, respiratory
protection or other safety devices. Over 90% of new voluntary
business policyholders were inspected prior to offering a premium
quote.
In addition to these in-person safety trainings, we provide our
policyholders with online resources for education and training that
are available 24/7. We believe our inspections and safety
training help protect workers and prevent catastrophic workplace
accidents. Employers value us for being their safety partners and
our agents value the depth of our safety resources. Our mission of
providing quality insurance services to our customers is reflective
of our commitment to the health and safety of our employees and
insureds.
- 23 -
Customer-focused Approach. We are proud of our
personal, high-touch model with policyholders. In the event of a
claim, our adjusters are on the ground
working with injured workers generally
within 48 hours
of the filed claim. We are physically there to represent the
injured worker, walk them through the claims process, and improve
the quality of their outcomes. One adjuster is solely responsible for
each injured worker and the claim loads of our
adjusters are less than half that
of other peers. Our customer-focused approach allows us to provide
high quality of service and a customer retention rate of over
90%.
Our Employees. The retention, growth, and
development of our employees is critical to our
success. We believe our average employee tenure of 10.7
years speaks to our successful efforts on these fronts.
We are committed to the health, safety and wellness of our
employees, as the success of our business is fundamentally
connected to the well-being of our people. Our benefit offerings
are designed to meet the varied and evolving needs of a diverse
workforce.
We provide employees with a 401K plan with company matching
contributions, health insurance plans, dental, vision and other
employee benefits. We also provide employees time off for annual
wellness exams, reimbursements of health club memberships,
confidential counseling services, quarterly wellness luncheons and
an annual health fair to promote a culture of wellness. The Company
has also established an endowment to provide scholarships to
dependents of our employees and members of the community in which
we do business, recognizing the importance of educating future
generations. Since 2016 we have maintained a partnership with the
Community Foundation of Southwest Louisiana to provide tax-free
assistance to employees that have experienced a catastrophic event
through an employee assistance fund. In addition to funding
provided by the Company, this fund also allows employees to make a
monetary donation to assist their fellow employees.
COVID-19 Pandemic Response. We continued to monitor the
health and safety of our employees during 2021 in response to the
ongoing COVID-19 pandemic. While much of 2020 initially
involved efforts to minimize non-essential travel, work-from-home
and limited in-person visits due to COVID-19, the Company did begin
returning our Safety, Claims, Audit and Sales employees to the
field and employees back to the home office in June of 2020, all
following local, state and federal health and safety
guidelines. During 2021, we continued to maintain
guidelines for in-person employees to ensure safety during the
pandemic. We also have encouraged employees to get
vaccinated by offering a monetary incentive, as well as time off
for vaccinations and testing.
Board Leadership
The Board has appointed Jared A. Morris as Chairman of the Board.
As Chairman, his key responsibilities include:
|
•
|
calling meetings of directors and independent directors;
|
|
•
|
presiding at the annual meeting, meetings of the Board, including
executive sessions of the independent directors;
|
|
•
|
acting as liaison between the board and management;
|
|
•
|
overseeing the preparation of proxy materials;
|
|
•
|
working with the NCG Committee to ensure proper committee
structure, including reviewing committee and committee chair
assignments, and the effectiveness of the Board;
|
|
•
|
approving the quality, quantity, appropriateness and timeliness of
information sent to the Board as well as setting meeting
agendas;
|
|
•
|
facilitating the Board’s approval of the number and frequency of
Board and committee meetings as well as meeting schedules to assure
that there is sufficient time for discussion of all agenda items;
and
|
|
•
|
any such other actions or duties deemed necessary by the Board.
|
- 24 -
Our Corporate Governance Guidelines do not require that the roles
of Chairman of the Board and Chief Executive Officer be held by
different persons, as the Board believes that effective board
leadership structure can depend on the experience, skills and
personal interaction among individuals in leadership roles. These
leadership roles are currently filled separately by our
non-executive Chairman of the Board, Jared A. Morris, and by our
Chief Executive Officer, G. Janelle Frost. The Board believes this
leadership structure affords the Company an effective combination
of management and non-management experience, continuity and
independence that currently serves the Board and the Company well.
Director Independence
As part of the Company’s corporate governance guidelines, the Board
has established a policy requiring a majority of the members of the
Board to be independent, as that term is defined in the Nasdaq
listing requirements. The Board has determined that each of its
current non-employee directors, Mr. Brown, Ms. Fontenot,
Mr. Garcia, Mr. Greer, Mr. J. Morris, Mr. M. Morris,
Mr. Roach and Mr. Traynor, is independent of the Company and
its management within the meaning of the Nasdaq listing
requirements.
The following Board Diversity Matrix presents our Board diversity
statistics in accordance with Nasdaq Rule 5606, as self-disclosed
by our directors. While the Board satisfies the minimum objectives
of Nasdaq Rule 5605(f)(3) by having at least one director who
identifies as female and at least one director who identifies as a
member of an Underrepresented Minority (as defined by Nasdaq
Rules), as we pursue future Board recruitment efforts, our
Nominating and Corporate Governance Committee will continue to seek
out candidates who can contribute to the diversity of views and
perspectives of the Board. This includes seeking out individuals of
diverse races and ethnicities, a balance in terms of gender, and
individuals with diverse perspectives informed by other personal
and professional experiences.
|
Brown
|
Fontenot
|
Frost
|
Garcia
|
Greer
|
J. Morris
|
M. Morris
|
Roach
|
Traynor
|
Skills and Experience
|
|
|
|
|
|
|
|
|
|
Executive Leadership
|
P
|
P
|
P
|
P
|
|
P
|
P
|
P
|
|
Financial/Accounting
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
Human Resources/Compensation
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
Strategic Planning/Oversight
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
|
P
|
Innovation/Technology/Cybersecurity
|
|
|
|
P
|
|
|
|
|
P
|
Enterprise Risk Management
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
Corporate Governance and Sustainability
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
P
|
Marketing/Sales
|
P
|
|
|
|
P
|
P
|
P
|
|
P
|
Tenure and Independence
|
|
|
|
|
|
|
|
|
|
Tenure (years)(1)
|
7
|
5
|
5
|
11
|
<1
|
17
|
15
|
14
|
2
|
Independence
|
P
|
P
|
|
P
|
P
|
P
|
P
|
P
|
P
|
Gender Identity
|
|
|
|
|
|
|
|
|
|
Male
|
P
|
|
|
P
|
P
|
P
|
P
|
P
|
P
|
Female
|
|
P
|
P
|
|
|
|
|
|
|
Demographics
|
|
|
|
|
|
|
|
|
|
Age
|
58
|
68
|
51
|
65
|
57
|
47
|
77
|
71
|
53
|
African American or Black
|
|
|
|
|
P
|
|
|
|
|
Hispanic
|
|
|
|
P
|
|
|
|
|
|
White
|
P
|
P
|
P
|
|
|
P
|
P
|
P
|
P
|
__________
1.Board tenure reflects service on the Board since the Company’s
initial public offering in 2005.
- 25 -
Board Meetings
The Board held five meetings during 2021. Each director serving on
the Board in 2021 attended at least 75% of the total number of
meetings of the Board and committees on which he or she served.
Under the Company’s corporate governance guidelines, each director
is expected to devote the time necessary to appropriately discharge
his or her responsibilities and to rigorously prepare for, attend
and participate in all Board meetings and meetings of Board
committees on which he or she serves.
Annual Meetings of Shareholders
The Company’s directors are encouraged to attend our annual
shareholder meetings, but we do not currently have a policy
relating to directors’ attendance at these meetings. Six of our
then eight directors, Mr. J. Morris, Mr. Brown, Mr.
Garcia, Ms. Fontenot, Ms. Frost, and Mr. Roach attended
our 2021 annual meeting of shareholders, either in person or by
teleconference.
Audit Committee
The Audit Committee currently consists of Mr. Garcia (Chair),
Mr. Brown, Ms. Fontenot, and Mr. J. Morris. The
Audit Committee oversees our accounting and financial reporting
processes and the audits of the Company’s financial statements. The
functions and responsibilities of the Audit Committee include:
|
•
|
reviewing, monitoring and assessing the Company’s policies and
compliance procedures with respect to business practices, including
the adequacy of the Company’s internal controls over accounting and
financial reporting;
|
|
•
|
engaging the Company’s independent registered public accounting
firm and conducting an annual review of the independence of that
firm;
|
|
•
|
pre-approving and approving any non-audit engagements with the
Company’s independent registered public accounting firm;
|
|
•
|
reviewing the annual audited financial statements and quarterly
financial information with management and the independent
registered public accounting firm, including disclosures regarding
internal controls;
|
|
•
|
reviewing with the independent registered public accounting firm
the scope and the planning of the annual audit;
|
|
•
|
reviewing and discussing with management the findings and
recommendations of the independent registered public accounting
firm;
|
|
•
|
discussing with the independent registered public accounting firm
the conduct of the annual audit, including management’s response;
|
|
•
|
overseeing compliance with applicable legal and regulatory
requirements and the Company’s Code of Conduct, including obtaining
applicable reports and assurances;
|
|
•
|
reviewing with the Company’s internal auditor the plans and scope
of audit activities and the annual report of audit activities,
examinations and related results;
|
|
•
|
establishing procedures for the receipt, retention and treatment of
complaints received by the Company regarding accounting, internal
accounting controls or auditing matters;
|
|
•
|
establishing procedures for the confidential, anonymous submission
by employees of concerns regarding questionable accounting or
auditing matters;
|
|
•
|
reviewing the appointment and replacement of the Company’s internal
audit officer and any third party internal audit service
provider;
|
|
•
|
discussing risk assessment and management policies and the
Company’s financial risk exposure;
|
|
•
|
discussing with the Company’s general counsel any legal matters
that may have a material impact on the Company’s financial
statements or compliance policies;
|
|
•
|
approving related party transactions exceeding $50,000 in aggregate
value;
|
- 26 -
|
•
|
reviewing the adequacy of the Audit Committee charter on an annual
basis; and
|
|
•
|
preparing the Audit Committee report to be included in our annual
proxy statement.
|
The Audit Committee met six times during 2021. Our independent
registered public accounting firm reports directly to the Audit
Committee. Each member of the Audit Committee has the ability to
read and understand fundamental financial statements. The Board has
determined that each member of the Audit Committee is “independent”
as defined in the Nasdaq listing requirements and SEC requirements
relating to the independence of audit committee members. The Board
has also determined that Mr. Brown, Ms. Fontenot,
Mr. Garcia and Mr. J. Morris each meet the requirements of an
“audit committee financial expert” as defined by SEC rules. The
Audit Committee has the authority to engage independent counsel and
other advisors as the Committee deems necessary to carry out its
duties.
Compensation Committee
The Compensation Committee currently consists of Mr. Brown
(Chair), Mr. Garcia, Mr. J. Morris, Mr. Roach and
Mr. Traynor. The Compensation Committee has sole authority for
establishing, administering and reviewing the Company’s policies,
programs and procedures for compensating our executive officers and
the members of the Board. The Compensation Committee may delegate
its responsibilities to a subcommittee comprised of Compensation
Committee members. The functions and responsibilities of the
Compensation Committee include:
|
•
|
reviewing, determining and approving, at least annually, corporate
goals and objectives relevant to the compensation of the Company’s
executive officers;
|
|
•
|
evaluating the performance of and determining the compensation for
the Company’s executive officers, including its chief executive
officer;
|
|
•
|
administering and making recommendations to the Board with respect
to the Company’s equity and incentive compensation plans;
|
|
•
|
performing a risk assessment of the Company’s compensation plans
and policies;
|
|
•
|
overseeing regulatory compliance with respect to compensation
matters;
|
|
•
|
reviewing and approving employment or severance arrangements with
the Company’s executive officers;
|
|
•
|
overseeing the
Company’s policies and practices relating to human capital and
workforce diversity matters;
|
|
•
|
reviewing director compensation policies and making recommendations
to the Board;
|
|
•
|
engaging, and determining the independence of, any compensation
consultant;
|
|
•
|
reviewing compliance with the Company’s stock ownership guidelines
by our executive officers;
|
|
•
|
reviewing the adequacy of the Compensation Committee charter on an
annual basis; and
|
|
•
|
reviewing and approving the Compensation Discussion and Analysis
and the Compensation Committee Report to be included in our annual
proxy statement.
|
The Compensation Committee met six times during 2021. The Board has
determined that each member of the Compensation Committee is
independent under the Nasdaq listing requirements.
The Compensation Committee has the sole authority to retain and
terminate compensation consultants to assist in the evaluation of
director or executive officer compensation and the sole authority
to approve the fees and other retention terms of such compensation
consultants. The committee may also retain independent counsel and
other independent advisors to assist it in carrying out its
responsibilities.
- 27 -
Nominating and Corporate Governance Committee
The NCG Committee currently consists of Mr. Roach (Chair),
Ms. Fontenot, Mr. J. Morris and Mr. Traynor. The
functions and responsibilities of the NCG Committee include:
|
•
|
developing and recommending corporate governance principles and
procedures applicable to the Board and the Company’s employees;
|
|
•
|
recommending committee composition and assignments;
|
|
•
|
identifying individuals qualified to become directors;
|
|
•
|
recommending director nominees;
|
|
•
|
recommending whether incumbent directors should be nominated for
re-election to the Board;
|
|
•
|
reporting, at least annually, on succession planning, including
appropriate contingencies in case our Chief Executive Officer
retires, resigns or is incapacitated;
|
|
•
|
reviewing any possible conflicts of interest of directors or
management;
|
|
•
|
providing oversight of the Company’s
policies, strategies and programs related to environmental, social
and corporate governance matters relevant to the Company, in
coordination with the Company’s other committees as
appropriate;
|
|
•
|
reviewing the adequacy of the NCG Committee charter on an annual
basis; and
|
|
•
|
overseeing, at least annually, an
evaluation of the performance of the Board and the Company’s
management in relation to the Company’s corporate governance
guidelines.
|
The NCG Committee met four times during 2021. The Board has
determined that each member of the NCG Committee is independent
under the Nasdaq listing requirements.
The NCG Committee has the sole authority to retain and terminate
any search firm to assist in the identification of director
candidates and the sole authority to set the fees and other
retention terms of such search firms. The committee may also retain
independent counsel and other independent advisors to assist it in
carrying out its responsibilities.
Qualifications for Director Nominees. In considering director
nominees, the NCG Committee considers a number of factors,
including the following:
|
•
|
whether the nominee is “independent” as determined in accordance
with the rules promulgated by the SEC, the Nasdaq listing
requirements and the Company’s corporate governance guidelines;
|
|
•
|
the ability and willingness to participate in Board activities,
including attendance at, and active participation in, Board and
committee meetings;
|
|
•
|
the ability and willingness to represent the best interests of all
of the Company’s shareholders;
|
|
•
|
personal and professional qualities, characteristics, attributes,
accomplishments and reputation in the business community, insurance
industry and otherwise;
|
|
•
|
increasing the diversity of viewpoints, backgrounds and experiences
in addition to those of existing directors and other nominees;
|
|
•
|
consistent demonstration of integrity;
|
|
•
|
the ability to exercise sound business judgment;
|
|
•
|
current knowledge and relationships in the markets and regions in
which the Company does business and in the insurance industry and
other industries relevant to the Company’s business;
|
- 28 -
|
•
|
reputation in a particular field or area of expertise;
and
|
|
•
|
the skills and personality of the nominee and how the committee
perceives the nominee will be a fit with existing directors and
other nominees in maintaining a Board that is collegial and
responsive to the needs of the Company and its shareholders.
|
The NCG Committee will also consider other criteria for director
candidates included in its committee charter, the Company’s
corporate governance guidelines or as may be established from time
to time by the Board. The NCG Committee has not adopted a separate
policy pertaining to the consideration of diversity in the
selection of nominees to the Board; however, as noted above,
diversity is one factor considered by the NCG Committee in
evaluating director candidates. The NCG Committee will identify
nominees based upon recommendations by committee members or other
Board members, members of the Company’s management or, as discussed
below, by shareholders of the Company. Upon identifying a potential
nominee, members of the NCG Committee will interview the candidate,
and based upon that interview, make a recommendation to the
Board.
Shareholder Recommendations. The Company has adopted a
policy regarding shareholder recommended director candidates, a
copy of which is available on the Investors section of the
Company’s website. Consistent with this policy, the NCG
Committee will evaluate director candidates recommended by a
shareholder according to the same criteria as a candidate
identified by the NCG Committee.
Shareholders may recommend candidates at any time, but to be
considered by the NCG Committee for inclusion in the Company’s
proxy statement for the next annual meeting of shareholders,
recommendations must be submitted in writing no later than 150
calendar days before the first anniversary of the date on which the
Company first mailed its proxy materials for the prior year’s
annual meeting of shareholders. A shareholder’s notice must contain
the following:
|
•
|
the name of the shareholder recommending the director candidate for
consideration, the name of the director candidate, and the written
consent of the shareholder and the director candidate to be
publicly identified;
|
|
•
|
a written statement by the director candidate agreeing to be named
in the Company’s proxy materials and to serve as a member of the
Board (and any committee of the Board to which the director
candidate is assigned to serve by the Board) if nominated and
elected;
|
|
•
|
a written statement by the shareholder and the director candidate
agreeing to make available to the NCG Committee all information
reasonably requested in connection with the NCG Committee’s
consideration of the director candidate; and
|
|
•
|
the director candidate’s name, age, business and residential
address, principal occupation or employment, number of shares of
the Company’s common stock and other securities beneficially owned,
a resume or similar document detailing personal and professional
experiences and accomplishments and all other information relating
to the director candidate that would be required to be disclosed in
a proxy statement or other filing made in connection with the
solicitation of proxies for the election of directors pursuant to
the Exchange Act, SEC rules and the listing requirements and other
criteria established by Nasdaq.
|
The shareholder’s notice must be signed by the shareholder
recommending the director candidate for consideration and sent to
the following address: AMERISAFE, Inc., 2301 Highway 190 West,
DeRidder, Louisiana 70634, Attn: Corporate Secretary (Nominating
and Corporate Governance Committee Communication/Director Candidate
Recommendation).
- 29 -
Risk Committee and Risk Management
The Board views risk management as one of its primary oversight
responsibilities. The Board initially formed the Risk Committee in
2010. The Risk Committee’s charter provides that all members of the
Board are members of the Risk Committee. Mr. M. Morris serves
as chair of the Risk Committee and establishes the agenda for the
meetings. Risk Committee members periodically receive presentations
on risk-related topics from the Company’s management. The Committee
provides oversight in the areas described below. In performing this
oversight function, at least annually and more frequently as may be
appropriate, the committee meets with Company management to review
these operational areas:
|
•
|
Underwriting. Review
the strategies, processes, and controls pertaining to the
underwriting of insurable risks and the pricing of such risks,
including new insurance products or lines of business that are
likely to have a positive or negative material impact on the
Company’s risk profile.
|
|
•
|
Claims. Review the
strategies, processes, and controls relating to the settlement of
claims.
|
|
•
|
Investment Operations. Review
the strategies, processes, and controls pertaining to the Company’s
investment operations. This review includes long-term
strategy, the Company’s investment policy & guidelines,
investment performance and liquidity, compliance with applicable
laws and regulations, any changes to investment accounting methods
and the approval of the hiring of external investment managers, if
any.
|
|
•
|
Retention Levels and Reinsurance. Review
the strategies, processes, and controls pertaining to the Company’s
determination of appropriate levels of retention of insured risk
and appropriate levels and types of reinsurance for its insurance
subsidiaries, as well as the financial strength of the reinsurers
with whom they conduct business;
|
|
•
|
Risk and Information Services. Oversee
the implementation, execution, and performance of the Company’s
enterprise risk management program;
|
|
•
|
Business Continuity Plan. Review
the strategies, processes, and controls pertaining to business
continuity and executive crisis management for the Company and its
business operations; and
|
|
•
|
Cybersecurity Practices. Review
the Company’s strategies, governing and management framework,
security principles, training and evaluations for cybersecurity
threats;
|
The Committee also coordinates with the Company’s other committees
regarding risks stemming from matters over which these other
committees have primary oversight responsibility, including risks
stemming from the ESG-related matters. Further, on an ad hoc basis,
and as otherwise directed by the Board, the Committee reviews
specific operational segments of the Company that may pose unusual
and significant risks that could have a material impact on the risk
profile of the Company.
The Risk Committee met four times in 2021. The Risk Committee has
the authority to select, retain, terminate, and approve the fees
and other terms of retention of special counsel, experts and
consultants. This Committee also has direct access to all Company
employees.
In addition to the activities of the Risk Committee, the Board
monitors risks arising from financial reporting and controls
through its Audit Committee and risks related to compensation
through its Compensation Committee.
Succession Planning
Our Board considers the evaluation of management and succession
planning to be one of its most important responsibilities. The
Board’s goal is to have a long-term program for effective senior
leadership and development, with appropriate contingencies in case
our chief executive officer, or any of our other executive
officers, retires, resigns or is incapacitated.
- 30 -
In the Board’s succession planning program, internal candidates for
the executive positions, including the chief executive officer,
are
identified
and evaluated based on criteria considered predictive of success at
the senior management level. This program incorporates 360 reviews
and related evaluations for
each individual.
The assessment includes a development plan, including executive
coaching, for
each individual.
Our Corporate Governance Guidelines provides that the NCG Committee
report to the Board on succession planning at least annually. The
chief executive officer is responsible for advising the Board
regarding her recommendations and evaluations of potential
successors, together with a review of any development plans for
these individuals. The Board, with the assistance of the NCG
Committee, evaluates potential successors to the CEO, as well as
other members of senior management.
Communications with the Board
Any shareholder or other interested party who wishes to communicate
directly with the Board or any of its members may do so by writing
to: Board of Directors, c/o AMERISAFE, Inc., 2301 Highway 190 West,
DeRidder, Louisiana 70634, Attn: Corporate Secretary. The mailing
envelope should clearly indicate whether the communication is
intended for the Board as a group, the non-employee directors or a
specific director.
- 31 -
COMPENSATION
DISCUSSION AND ANALYSIS
This Compensation Discussion and Analysis, or CD&A, is designed
to provide shareholders with an understanding of the Company’s
compensation philosophy and objectives, as well as the analysis
that the Compensation Committee (referred to in this CD&A as
the “Committee”) performed in setting executive compensation. It
discusses the determination of how and why, in addition to what,
actions were taken by the Committee with respect to compensation
for each of our executive officers during 2021. Those individuals
are:
|
•
|
G. Janelle Frost, President and Chief Executive Officer
|
|
•
|
Neal A. Fuller, Executive Vice President and Chief Financial
Officer
|
|
•
|
Vincent J. Gagliano, Executive Vice President and Chief Risk
Officer
|
|
•
|
Andrew B. McCray,
Executive Vice President and Chief Underwriting Officer
|
|
•
|
Kathryn H. Shirley, Executive Vice President, Chief Administrative
Officer and Secretary
|
Executive Summary
Recent Company Performance
We are a holding company that markets and underwrites workers’
compensation insurance through our insurance subsidiaries. The
Company had solid operating performance during 2021, in a declining
premium environment, with net income of $65.8 million and a
combined ratio of 85.7% in the insurance industry. Our earnings per
diluted share were $3.39 and our return on average equity was 15.7%
compared with $4.47 and 19.9% in 2020. Total shareholder return was
2.3% in 2021, compared to the P&C Small-Cap Index of 16.5% and
the P&C Mid-Cap Index of 21.3%. The Company’s average annual
total shareholder return for the three-year and five-year periods
ended December 31, 2021 was 6.1% and 4.6%, respectively. The
P&C Small Cap Index average annual return for the three and
five-year periods ended December 31, 2021 was 8.5% and 7.7%,
respectively. The P&C Mid-Cap Index average annual
return for the three-year and five-year periods ended December 31,
2021 was 13.6% and 10.7%, respectively.
The Company also measures its performance by tracking its growth in
book value per share plus dividends paid to
shareholders. In 2021, this growth was $3.08 compared to
a starting book value per share of $22.70, for a change of
13.6%. For the three years ended in 2021, this growth
was $13.60 off a starting book value of $21.26, for an average
annual change of 17.9%. For the five years ended in
2021, this growth was $19.82 off a starting book value of $23.72,
for an average annual change of 12.9%.
In 2021, the Company paid regular quarterly dividends of $1.16 per
share and an extraordinary dividend of $4.00 per share, or total
dividends of $5.16 per share. Effective February 2022, the Board of
Directors increased the regular quarterly dividend from $0.29 per
share to $0.31 per share, an increase of 6.9%. Although the Board
presently intends to pay a regular quarterly dividend, dividends
are considered each quarter for approval.
Compensation Best Practices
The Committee annually reviews and periodically modifies our
executive compensation program to retain and attract top executive
talent to the Company and ensure that our program is both aligned
with the interests of our shareholders and meets evolving
governance standards. The following highlights some of the
compensation and governance best practices that are part of our
program:
|
•
|
Performance-Based Annual Incentive
Plan—Our annual incentive compensation plan, as implemented
in 2019, rewards our executives for achievement of pre-established
individual performance goals.
|
|
•
|
LTIP Awards are
Performance-Based—Since 2017, 100% of the awards under our
long-term incentive program for executive management are in the
form of performance awards that reward exceptional financial
performance relative to a peer group of property and casualty
insurers and include a reduction if our total shareholder return
does not exceed a certain level relative to comparative
indexes.
|
- 32 -
|
•
|
No Tax
“Gross-Ups”—We
do not provide
any tax “gross-up” payments in connection with compensation or
other benefits provided by the Company.
|
|
•
|
Clawback Policy—Both our
annual and long-term incentive awards are subject to a compensation
recoupment policy that permits the Committee to seek recovery of
incentive awards paid if there is a restatement of the Company’s
financial statements.
|
|
•
|
Independent Compensation Consultant—The Committee
engages an independent compensation consultant to prepare surveys
of executive officer and director compensation based on a peer
group comprised of publicly traded companies.
|
|
•
|
Double Trigger Severance
Payments—The employment agreements with our executive
officers do not provide for single trigger cash payments upon a
change in control; our executives are entitled to severance only
upon certain circumstances as the result of a termination of
employment, and these payments are the same whether or not the
termination is related to a change in control.
|
|
•
|
Double Trigger
Vesting—Awards under our long-term incentive program only
vest in connection with a change in control if the executive
experiences a qualifying termination of employment.
|
|
•
|
Risk Review—The Committee
conducts an annual risk review of the Company’s executive
compensation program, policies and practices.
|
|
•
|
Oversight of 10b5-1
Plans—The Board adopted 10b5-1 policies and procedures,
which include Board oversight of 10b5-1 plan transactions.
|
|
•
|
Independent Advisors—The
Committee ensures the independence of all Committee advisors by
limiting the advisors ability to perform other services for the
Company.
|
|
•
|
Anti-Hedging and Anti-Pledging
Policies—The Company prohibits its executives, directors and
employees from hedging or pledging Company securities.
|
|
•
|
Stock Ownership and Holding
Requirements—Our executive officers are required to maintain
certain levels of ownership of Company securities and are required
to hold all shares received as compensation until the applicable
guideline amount is achieved (net of shares used or sold to pay the
exercise price or tax withholding). After meeting the applicable
guideline, our executive officers are required to hold 20% of the
shares received as compensation (net of shares used or sold to pay
the exercise price or tax withholding).
|
No 2021 Target Compensation Changes
For 2021, the Committee reviewed the base salaries and target
annual and long-term incentive compensation of our executive
officers. Consistent with the Company’s decision in July 2020 to
not increase base salaries for employees due to the pandemic and
ensuing economic implications, the Committee did not make any
changes to the executive officer base salaries or change any of the
annual and long-term incentive targets for the executive officers.
In addition, the Committee continues to place greater weight on
performance-driven long-term incentive compensation compared to
annual incentive compensation, recognizing that, as a mono-line
workers’ compensation insurance company, the claims incurred under
the policies written by the Company often take several years to
develop. In determining the long-term incentive awards for
2021, the Committee adjusted the weighting of the metrics to
increase the weight of direct premiums written to align with
Company performance goals.
Compensation Program Objectives
Our compensation program is intended to attract, retain and
motivate the key people necessary to enable our Company to operate
effectively and profitably over the long-term. The Committee
believes that executive compensation should align the interests of
the Company’s executives and other key employees with those of the
Company and its shareholders. Our compensation program is also
designed to differentiate compensation based upon individual
contribution, performance and experience with our Company.
- 33 -
In establishing compensation, the Committee seeks to provide
employees, including our executive officers, with a competitive
total compensation package. The Committee sets compensation in this
manner to ensure that our compensation practices do not put the
Company at a disadvantage in attracting and retaining executives
and other employees, while also ensuring a competitive cost
structure for our Company.
Compensation Processes
Our compensation program for executives is designed and implemented
under the direction of the Committee, which is currently comprised
of the following five independent directors: Mr. Brown
(chair), Mr. Garcia, Mr. J. Morris, Mr. Roach and
Mr. Traynor. For additional information regarding our
Committee and its authority and responsibilities, see “The Board, Its Committees, and Its
Compensation—Compensation Committee.”
2021 Advisory Vote on Executive Compensation
At our annual meeting of shareholders in June 2021, more than 99%
of the votes cast on the say-on-pay proposal were in support of our
executive compensation program. The Committee considered the
results of this advisory vote and believes the results affirm
shareholder approval of the Board’s approach to the Company’s
executive compensation program. Although the Committee did not
adopt any changes to our program as a result of this vote, as noted
above the Committee is continually evaluating our executive
compensation and has made changes in the past few years to further
align the program with our shareholders’ interests and to take into
consideration the results of market surveys and other information
prepared by the Committee’s compensation consultant.
Role of Compensation Consultant
Since early 2012, the Committee has engaged McLagan, an AON Hewitt
Company, as its independent compensation consultant. Pursuant to
Company policy, McLagan does not provide services to the Company
other than the consulting services it provides to the Committee.
The Committee is solely responsible for the appointment,
compensation and oversight of the compensation consultant.
McLagan attends Committee meetings, when requested by the
Committee, prepares executive compensation surveys, and generally
advises on executive compensation matters including the peer group
composition for purposes of the surveys, pay levels and pay
composition, and annual and long-term incentive plan design.
McLagan also provides market data, analysis, and advice regarding
the CEO and executive officer compensation to the Committee as well
as director compensation surveys and advice. As required by SEC
rules, the Committee assessed the independence of McLagan and
concluded that McLagan’s work did not raise any conflicts of
interest.
Compensation Surveys
McLagan conducted the most recent executive compensation survey in
2019. The “2019 Survey”, reviewed by the Committee in the fall of
2019, was used in setting compensation for 2020 and was referred to
when the Committee considered its 2021 compensation decisions.
Given the impact and uncertainty of the COVID-19 pandemic, the
Committee did not engage McLagan in 2020 for a compensation survey.
The Committee did engage McLagan for a survey in 2021 to assess
2022 executive compensation.
The 2019 Survey compared the compensation for our executive
officers against a peer group of 16 publicly traded insurance
companies. The 2019 Survey also included a review of the Company’s
annual and long-term incentive compensation plan design. McLagan
used Company target compensation for 2019 and peer group
compensation data for 2018 in its preparation of the 2019 Survey.
The Committee reviewed the 2019 Survey results in assessing the
level of salary and bonuses paid to our executives and approving
changes to the target compensation levels and annual and long-term
compensation plan design for our executive officers in 2020.
- 34 -
Peer Group Construction. The Committee used a
rigorous process to select peer companies for benchmarking
executive pay in the 2019 survey,
which included
ranking the companies by premiums written, total
revenue, combined
ratio,
lines of insurance business, multi-line versus mono-line
property-casualty insurer, number of states doing business in, and
investment mix. With the assistance of McLagan, the
Committee
selected
the
following 16 publicly traded
companies as its peer group for the
2019 Survey:
•Atlantic American Corp.
|
•Kingstone Companies,
Inc.
|
•Conifer Holdings, Inc.
|
•Kinsale Capital Group, Inc.
|
•Donegal Group
|
•NI Holdings, Inc.
|
•Employers Holdings, Inc.
|
•Proassurance Corporation
|
•Global Indemnity Limited
|
•Protective Insurance Corporation
|
•Hallmark Financial Services
|
•RLI Corp
|
•ICC Holdings
|
•Safety Insurance Group
|
•James River Group Holdings
|
•United Fire Group, Inc.
|
As noted in the Company’s 2021 proxy statement, the results of the
2019 Survey indicated that (1) the Company’s aggregate executive
officer 2019 target compensation was below the market median for
each pay element, (2) the average total target direct compensation
for each of the named executive officers was below the market
median, (3) the Company delivers a greater percentage of total
target direct compensation in the form of incentive (or variable)
compensation than its peers and (4) the Company delivers a greater
proportion of incentive compensation in annual incentive pay.
Role of Management
Our chief executive officer, Ms. Frost, makes recommendations
with respect to changes in base salary for our executive officers,
other than for herself. As noted above, there were no increases in
the base salaries of our executive officers in 2021. She also makes
recommendations regarding the level of achievement of individual
performance goals under our annual incentive compensation plan by
each executive officer other than herself. Although the Committee
considers the recommendations of Ms. Frost, the Committee
makes all final determinations regarding executive compensation.
Ms. Frost is not present when the Committee discusses or
determines her compensation.
Risk Assessment
The Committee annually considers the risk to the Company of the
design and objectives of its executive compensation plans through
review of the compensation surveys provided by McLagan. The primary
risk is weighting the premium growth factor too heavily in the
annual and long-term incentive plans. Growing premium too rapidly
could result in poor underwriting results and ultimately affect the
financial strength of the Company.
The Committee recognizes that the design and objectives of the
executive compensation plans are based on assumptions that may
later be determined to be inaccurate which could present a risk of
loss of key personnel resulting in disruption of our operations and
adverse effects on our business. The Committee believes the current
relative weighting of the metrics in the annual and long-term
incentive plans are appropriately balanced to attract, retain and
motivate key employees as well as align with shareholder
interests.
- 35 -
Overview of Executive Compensation Program
The principal components of our executive compensation program
provide for a combination of fixed and variable compensation. In
addition to the principal components, we also provide our executive
officers with broad-based employee benefits, certain severance
benefits and limited perquisites. For 2021, the principal
components, which we refer to as our executive officer’s total
direct compensation, are summarized as follows:
2021 Executive Compensation Program at a Glance
Compensation
Element
|
Characteristics
|
Base Salary
|
• Fixed cash compensation
• Reviewed annually, and upon
promotion or upon a change in job responsibilities
• Used in determining target awards
for incentive compensation
|
Annual Incentive
Compensation
|
• Annual variable cash compensation
based on pre-established individual qualitative leadership
objectives
• Target award is a percentage of base
salary—for 2021, these percentages are 60% for our CEO, 35% for our
CFO and 30% for each of our other executive officers
• Maximum payout is 150% of target
award
|
Long-Term
Equity-Based
Compensation
(LTIP)
|
• Target LTIP award is a percentage of
base salary—110% for our CEO and 55% for each of our other
executive officers
• 100% of performance awards are
payable in shares of common stock after a three-year performance
period
• Applicable metrics: combined ratio
(70% of award) and direct premiums written (30% of award) measured
against a peer group of predominately property and casualty
insurance companies
• Earned amount subject to reduction
based on our total shareholder return relative to appropriate
indexes
• Maximum payout is capped at 150% of
target award
|
The table below summarizes our executive officers’ target direct
compensation approved for 2021 as well as the percentage of total
target direct compensation represented by each component. As noted,
over 60% of our chief executive officer’s total target compensation
is at-risk and based on achievement of individual and Company
performance objectives. The actual base salary received, the actual
annual incentive compensation award earned for 2021 and the grant
date value of LTIP awards are reflected in “Executive Compensation—Summary Compensation
Table.”
|
|
2021
Base Salary
|
|
|
2021 Target
AIP Award
|
|
|
2021 Target
LTIP Award
|
|
|
2021
|
|
Executive
|
|
$
|
|
|
% of
Total
|
|
|
$
|
|
|
% of
Total
|
|
|
$
|
|
|
% of
Total
|
|
|
Total Target
Compensation
|
|
G. Janelle Frost
|
|
$
|
681,000
|
|
|
37%
|
|
|
$
|
408,600
|
|
|
22%
|
|
|
$
|
749,100
|
|
|
41%
|
|
|
$
|
1,838,700
|
|
Neal A. Fuller
|
|
$
|
435,000
|
|
|
53%
|
|
|
$
|
152,250
|
|
|
18%
|
|
|
$
|
239,250
|
|
|
29%
|
|
|
$
|
826,500
|
|
Vincent J. Gagliano
|
|
$
|
322,000
|
|
|
54%
|
|
|
$
|
96,600
|
|
|
16%
|
|
|
$
|
177,100
|
|
|
30%
|
|
|
$
|
595,700
|
|
Andrew B. McCray
|
|
$
|
291,000
|
|
|
54%
|
|
|
$
|
87,300
|
|
|
16%
|
|
|
$
|
160,050
|
|
|
30%
|
|
|
$
|
538,350
|
|
Kathryn H. Shirley
|
|
$
|
297,000
|
|
|
54%
|
|
|
$
|
89,100
|
|
|
16%
|
|
|
$
|
163,350
|
|
|
30%
|
|
|
$
|
549,450
|
|
- 36 -
Base Salary. Base salaries are
determined on the basis of management responsibilities and level of
experience, as well as internal and market comparisons. In setting
base salaries for our executive officers, the Committee seeks to
provide a reasonable level of fixed compensation that we believe is
competitive with base salaries for comparable positions at our peer
companies.
Consistent with the Company’s decision in July 2020 to not increase
base salaries for employees due to the pandemic and ensuing
economic implications, the Committee did not make any changes to
the executive officer base salaries for 2021.
Executive
|
|
2021
Base Salary
|
|
|
2020
Base Salary
|
|
|
Percentage
Increase
|
|
G. Janelle Frost
|
|
$
|
681,000
|
|
|
$
|
681,000
|
|
|
0.0%
|
|
Neal A. Fuller
|
|
$
|
435,000
|
|
|
$
|
435,000
|
|
|
0.0%
|
|
Vincent J. Gagliano
|
|
$
|
322,000
|
|
|
$
|
322,000
|
|
|
0.0%
|
|
Andrew B. McCray
|
|
$
|
291,000
|
|
|
$
|
291,000
|
|
|
0.0%
|
|
Kathryn H. Shirley
|
|
$
|
297,000
|
|
|
$
|
297,000
|
|
|
0.0%
|
|
Annual Incentive Compensation. The Committee believes that
annual incentive compensation is an important element of the total
compensation of each executive officer. Similar to the structure of
the program in 2020, in 2021, the Committee implemented an annual
incentive plan based on achievement of individual performance goals
instead of Company-focused performance metrics.
2021 Annual Incentive Compensation. In
February 2021, the Committee approved target award opportunities
under our annual incentive compensation plan for each executive
officer equal to a percentage of each executive’s base salary,
which percentages were consistent with those used in the 2020
program.
As in 2020, the Committee believed it was important to focus each
executive on key individual objectives for the year. Further, given
that the payout of our long-term incentive compensation awards is
driven by key metrics tracking Company performance (combined ratio,
direct premiums written and total shareholder return), the
Committee determined that structuring the annual incentive program
around individual performance goals continues to be appropriate. In
2021, the individual performance goals established were both
qualitative and quantitative for all of the executives, including
Ms. Frost, to focus management’s goals on improving Company
performance in a declining rate environment. The quantitative goal
established was designed to support the long-term objective of
increasing direct premiums written. Ms. Frost also was evaluated on
leadership of the senior management team. For our other executive
officers, individual goals were focused on completion of individual
special projects.
The following table sets forth the target award opportunity for
each named executive officer for 2021.
Executive
|
|
Target Value of
Annual
Incentive
Opportunity
|
|
Target Annual Incentive
Opportunity
(% of Base Salary)
|
|
|
G. Janelle Frost
|
|
$
|
408,600
|
|
60%
|
|
|
Neal A. Fuller
|
|
$
|
152,250
|
|
35%
|
|
|
Vincent J. Gagliano
|
|
$
|
96,600
|
|
30%
|
|
|
Andrew B. McCray
|
|
$
|
87,300
|
|
30%
|
|
|
Kathryn H. Shirley
|
|
$
|
89,100
|
|
30%
|
|
|
Each executive officer could earn between 0% and 150% of the target
individual goals based on the level of achievement of the
applicable goals. The committee evaluated each executive’s
performance against his or her performance goals to determine the
achievement levels under the 2021 annual incentive plan,
considering the recommendations of Ms. Frost for the executives
other than herself. For 2021, the quantitative goal was not
achieved, which impacted the percentage target award earned.
- 37 -
The
total annual incentive award payouts for our named executive
officers for 2021
were as follows:
Executive
|
|
|
Total Award (Individual Performance)
|
|
|
|
Percent of Target
Award Earned
|
|
|
G. Janelle Frost
|
|
|
$
|
194,085
|
|
|
|
48%
|
|
|
Neal A. Fuller
|
|
|
$
|
100,420
|
|
|
|
66%
|
|
|
Vincent J. Gagliano
|
|
|
$
|
82,110
|
|
|
|
85%
|
|
|
Andrew B. McCray
|
|
|
$
|
63,293
|
|
|
|
73%
|
|
|
Kathryn H. Shirley
|
|
|
$
|
75,735
|
|
|
|
85%
|
|
|
Long-Term Incentive Compensation. Under our current program,
the Committee makes LTIP awards on an annual basis, but may adjust
the performance factors, the weighting of those factors, and other
aspects of the LTIP each year as it evaluates the effectiveness of
the program over time. The following principles and objectives
guide the Committee in implementing our LTIP each year:
|
•
|
The program should be performance-based and compare the Company’s
operating performance to a peer group of companies engaged in the
workers’ compensation insurance industry.
|
|
•
|
The performance period should reflect the long-term nature of the
workers’ compensation claims development process.
|
|
•
|
Increased rigor should apply in order to receive maximum payout
under the performance awards, given the Company’s outstanding
operating performance and the fact that the Company has
outperformed the workers’ compensation industry on a combined ratio
basis over the past several years.
|
|
•
|
Payouts under the performance awards should be reduced if the
Company’s total shareholder return underperforms the industry in
order to further align the interests of the executive officers with
those of the Company’s shareholders.
|
Under the LTIP, target awards are established annually for each
executive officer based on a percentage of the executive’s base
salary. The target award value is delivered to each executive
solely in the form of a performance-based award. The performance
award is payable in shares of common stock, with the number of
shares earned determined based on the Company achievement of
certain quantitative targets measured over a three-year performance
period. These performance awards are tied directly to the
performance of the Company and better align executive management
compensation and shareholder interests.
The Compensation surveys continue to reaffirm the importance of the
LTIP in making the Company’s executive compensation program
competitive with peers. Awards under the LTIP are made pursuant to
our shareholder-approved 2012 Equity and Incentive Compensation
Plan.
2021 Long-Term Incentive Compensation Awards. For
the 2021 LTIP awards, the Committee set a target value, which was a
percentage of base salary as set forth below, which percentages
were consistent with those used in the 2020 program, for each
executive officer. Based on the 2019 Survey, the target for Ms.
Frost was slightly above the market median and the target for the
other executive officers was slightly below the market median for
the long-term compensation component of pay. This target value was
then awarded to each executive in the form of a performance
award.
Executive
|
|
Target
Value of
2021 LTIP
Awards (1)
|
|
|
Target Value as a
Percentage of
2021 Base Salary
|
|
G. Janelle Frost
|
|
$
|
749,100
|
|
|
110%
|
|
Neal A. Fuller
|
|
$
|
239,250
|
|
|
55%
|
|
Vincent J. Gagliano
|
|
$
|
177,100
|
|
|
55%
|
|
Andrew B. McCray
|
|
$
|
160,050
|
|
|
55%
|
|
Kathryn H. Shirley
|
|
$
|
163,350
|
|
|
55%
|
|
- 38 -
__________
1.
|
Following completion of the three-year performance period, the
earned performance awards will be payable in shares of our common
stock. These awards are further described under “Executive
Compensation—Grants of Plan Based Awards.”
|
Description of 2021 Performance Awards. The performance awards provide a target dollar
amount that may be earned by the executive, which amount will be
paid in shares of our common stock, subject to certain limited
exceptions. The amount earned under the performance award will be
between 0% and 150% of the award’s target value. The amount earned,
if any, is dependent on the Company’s operating performance over a
three-year period beginning on January 1, 2021 and ending
December 31, 2023, relative to the performance of a designated
peer group of insurance companies selected by the Committee. In
2021, the Committee reviewed the peer group selected for the
performance awards in 2019 and confirmed that the companies
selected continued to be significant competitors of the Company in
the workers’ compensation markets in which it operates. The
following 22 companies comprise the performance peer group for the
2021 performance awards under the LTIP:
• Accident Fund Group
|
• Employers Insurance Group
|
|
|
• ACUITY
|
• FCCI Mutual Insurance
Company
|
|
|
• Alaska National Insurance
Co.
|
• Federated Mutual Insurance
Company
|
|
|
• Amerisure Mutual Insurance
Company
|
• FFVA Mutual Insurance
Company
|
|
|
• BITCO General Insurance
Company
|
• Great West Casualty
Company
|
|
|
• BITCO National Insurance
Group
|
• Louisiana Workers Compensation
Corp.
|
|
|
• Builders Insurance
|
• National American Insurance
Company
|
|
|
• Builders Mutual Insurance
Company
|
• National Interstate
Corporation
|
|
|
• Cincinnati Financial
Corporation
|
• Protective Insurance
Corporation
|
|
|
• Donegal Insurance Group
|
• Sentry Insurance
|
|
|
• Eastern Insurance Holdings
|
• West Bend Mutual Insurance
Company
|
Consistent with the 2020 awards, the Committee selected the
following two metrics to measure the Company’s operating
performance under the 2021 performance-based awards: combined ratio
(“CR”), and direct premiums written (“DPW”), each determined on the
basis of statutory accounting principles used by insurance
companies (including the Company) in filings made with state
regulatory authorities. The Committee selected these measures as
they were deemed to be significant performance benchmarks for
insurance companies, including the Company. However, for the 2021
awards, the Committee slightly altered the weight of each metric,
reducing the weight of CR by 10% and correspondingly increasing the
weight of DPW by the same percentage placing an increased emphasis
on the growth of direct written premiums.
LTIP Metrics
|
Weighting
|
Description
|
Combined Ratio
|
70%
|
Defined as standard industry profitability measure and is
calculated as the sum of:
(1) incurred losses divided by net premiums earned;
(2) underwriting expenses divided by net premiums written; and
(3) dividends to policyholders divided by net premiums earned.
|
Direct Premiums Written
|
30%
|
Defined as gross premiums written minus assumed premiums
written
(for mandatory pooling arrangements)
|
Calculation of Earned Amounts under the Performance Awards.
Following the end of the
applicable three-year performance period, the Committee will
determine the percentage of the target award earned (the “Earned
Value”) as follows:
Step 1: Application of
Threshold Basis Points Concept to Calculation of Awards. In
designing the performance-based award under the LTIP, the Committee
recognized that the Company had demonstrated outstanding operating
performance and consistently outperformed the workers’ compensation
industry, including the peer companies listed above. As a
consequence, the Committee’s award design considered this
historical performance when determining the level of performance
that would result in maximum payout under the performance-based
awards. The Committee incorporated the concept of threshold basis
points (“TBP”) into the calculation of the Earned Value. TBP is the
amount by
- 39 -
which the Company’s performance for each measure must exceed the
results of the performance peer group for the payout of that
measure to equal two times the target level (as noted above, the
overall award is limited to 150% of the target award value). TBP is
expressed in basis points (“BP”). The first step in the calculation
of the Earned Value is to compare the performance of the Company
over the performance period to that of the 22 companies in the peer
group for the applicable performance and to determine whether the
TBP level for each measure has been achieved. For example, the TBP
for each measure in the 2021
performance awards were as follows:
Metric
|
Form
|
Threshold
Points
|
Threshold
|
Target
|
Maximum
|
Limits
|
Statutory
Combined Ratio
|
Relative to
22 peers
|
1200
|
1200 BP <
or = to
peer
group
|
Results
=
peer
group
|
1200 BP >
or = to
peer group
= 2x target
|
Payout factor
cannot
be <-1
|
Statutory Growth in
Direct Premiums
Written
|
Relative to
22 peers
|
500
|
500 BP <
or = to
peer
group
|
Results
=
peer
group
|
500 BP >
or = to
peer group
= 2x target
|
Payout factor
cannot
be <-1
|
Total sum of
metric results
|
|
|
zero
|
100%
of target
|
150% of target
award
|
|
Company Total
Shareholder Return
|
Relative to
50% S&P
P/C Ins
Mid-Cap Index
Plus
50% S&P P/C Ins
Small-Cap Index
|
500
|
|
|
|
Reduces the uncapped payout factor by 37.5 bp (basis points) for
every 500 bp of under-performance in the TSR factor, subject to a
maximum 25% reduction in the uncapped payout factor
|
Step 2: Reduction Based on
Total Shareholder Return. Following a determination of the
payout level based on the metrics described above, the payout will
be reduced if the total shareholder return (“TSR”) of the Company
is more than 500 basis points lower than the total shareholder
return of 50% of the S&P Property Casualty Insurance Small Cap
Index and 50% of the S&P Property & Casualty Insurance
Mid Cap Index over the three-year period. The TSR measure cannot
increase payouts under the awards, but is only used to reduce the
payout when the Company TSR lags the index by more than 500 basis
points. The TSR measure operates as a third metric in the award
design and reduces the uncapped payout factor by 37.5 basis points
for every 500 basis points of under-performance in the TSR factor,
subject to a maximum 25% reduction in the uncapped payout factor.
After the award is reduced by a TSR factor adjustment, if any, the
bonus factor is then subject to a 1.5 times target compensation
cap.
Step 3: Conversion of
Earned Value to Shares of Common Stock. After determination
of the Earned Value under each performance award, payment is made
in shares of common stock (rounded to the nearest whole share)
equal to (a) the Earned Value under the award divided by
(b) the volume weighted trading price per share of common
stock for the 10 trading days immediately preceding the date the
value of the award is approved by the Committee (after the
expiration of the three-year performance period).
Payout of the 2018-2020 Performance Awards. The following table sets forth the weighting
of performance measures established under the performance awards
for the 2018 - 2020 performance
- 40 -
period, and the results achieved.
The shares of common stock earned under this award were issued in
May 2021.
Metric
|
|
Weighting of Metric
|
|
Threshold
BP
|
|
|
Peer Result
|
|
|
Company
Result
|
|
|
Company/Peer
BP Difference
|
|
|
Calculated
Payout
Factor (1)
|
|
|
Payout Factor Used
|
|
Statutory Combined Ratio
|
|
80%
|
|
|
1,200
|
|
|
89.7%
|
|
|
78.4%
|
|
|
|
(1.135)
|
|
|
|
1.946
|
|
|
|
1.946
|
|
Statutory Growth in Direct Premiums Written
|
|
20%
|
|
|
500
|
|
|
(0.9)%
|
|
|
(4.5)%
|
|
|
|
(358)
|
|
|
|
0.284
|
|
|
|
0.284
|
|
Total Shareholder Return (2)
|
|
(37.5)%
|
|
|
500
|
|
|
18.2%
|
|
|
15.5%
|
|
|
|
(266)
|
|
|
|
—
|
|
|
|
—
|
|
__________
1.
|
For each executive, the total performance award is calculated using
the weighting applied of each metric to the applicable payout
factor.
|
2.
|
TSR reduces the payout factor by 37.5 points for every 500 basis
points of underperformance, capped at a negative 25% of the
uncapped award before applying the 1.5 times award cap.
|
- 41 -
The following table sets
forth the applicable target values, as well as the final payout,
under the performance award for the
2018-2020
performance periods for each named executive officer:
Executive (1)
|
|
Target Value of
Performance
Award
|
|
|
Bonus
Factor (2)
|
|
|
Award Value as of
May 17, 2021
|
|
|
Number of
Common
Shares (3)
|
|
G. Janelle Frost
|
|
$
|
577,500
|
|
|
|
1.500
|
|
|
$
|
866,250
|
|
|
|
13,458
|
|
Neal A. Fuller
|
|
$
|
195,250
|
|
|
|
1.500
|
|
|
$
|
292,875
|
|
|
|
4,550
|
|
Vincent J. Gagliano
|
|
$
|
143,000
|
|
|
|
1.500
|
|
|
$
|
214,500
|
|
|
|
3,332
|
|
Kathryn H. Shirley
|
|
$
|
126,500
|
|
|
|
1.500
|
|
|
$
|
189,750
|
|
|
|
2,948
|
|
__________
1.
|
Mr. McCray did not participate in the 2018-2020 LTIP.
|
2.
|
The bonus factor is the sum of the weighting of each performance
measure applied to the applicable payout factor. Combined ratio
(1.946 x .80) + Direct Premiums Written (0.284 x .20) – Total
Shareholder Return (0.00) = 1.613. The bonus factor was
reduced to 1.500, the maximum bonus factor allowed under the
plan.
|
3.
|
Based on the volume
weighted trading price per share for the 10 trading days
immediately preceding the date the value of the award is approved
by the Committee.
|
Current Estimates of Potential Payout Value of Outstanding
Performance Awards.
The following table shows the
estimated potential payout of the performance-based awards granted
in 2019, 2020 and 2021 as of September 30, 2021, which is the
most current information available to the Company. These estimated
values are presented for information purposes only, as the actual
payout values will be determined following the end of the
respective performance periods and will be impacted by the
Company’s performance during the remainder of the performance
periods.
Executive
|
|
Target Value of
Performance
Award
|
|
|
Current
Performance
Factor
Estimate (1)
|
|
|
Estimated
Award Value
as of 9/30/2021
|
|
G. Janelle Frost
|
|
|
|
|
|
|
|
|
|
|
|
|
2019-2021 Performance Period
|
|
$
|
731,500
|
|
|
|
1.475
|
|
|
$
|
1,079,036
|
|
2020-2022 Performance Period
|
|
$
|
749,100
|
|
|
|
1.316
|
|
|
$
|
986,059
|
|
2021-2023 Performance Period
|
|
$
|
749,100
|
|
|
|
0.850
|
|
|
$
|
636,461
|
|
Neal A. Fuller
|
|
|
|
|
|
|
|
|
|
|
|
|
2019-2021 Performance Period
|
|
$
|
233,750
|
|
|
|
1.475
|
|
|
$
|
344,805
|
|
2020-2022 Performance Period
|
|
$
|
239,250
|
|
|
|
1.316
|
|
|
$
|
314,931
|
|
2021-2023 Performance Period
|
|
$
|
239,250
|
|
|
|
0.850
|
|
|
$
|
203,275
|
|
Vincent J. Gagliano
|
|
|
|
|
|
|
|
|
|
|
|
|
2019-2021 Performance Period
|
|
$
|
173,250
|
|
|
|
1.475
|
|
|
$
|
255,561
|
|
2020-2022 Performance Period
|
|
$
|
177,100
|
|
|
|
1.316
|
|
|
$
|
233,121
|
|
2021-2023 Performance Period
|
|
$
|
177,100
|
|
|
|
0.850
|
|
|
$
|
150,470
|
|
Andrew McCray
|
|
|
|
|
|
|
|
|
|
|
|
|
2019-2021 Performance Period
|
|
$
|
136,373
|
|
|
|
1.475
|
|
|
$
|
201,163
|
|
2020-2022 Performance Period
|
|
$
|
160,050
|
|
|
|
1.316
|
|
|
$
|
210,678
|
|
2021-2023 Performance Period
|
|
$
|
160,050
|
|
|
|
0.850
|
|
|
$
|
135,984
|
|
Kathryn H. Shirley
|
|
|
|
|
|
|
|
|
|
|
|
|
2019-2021 Performance Period
|
|
$
|
|